|
|
·|û¡G·Æ½ü8ªÎ10136452 µoªí®É¶¡:2017/5/13 ¤U¤È 05:23:24
|
·PÁÂOBI¤j¦b «¼C¤j¡¨2015¦~4Q¤¤¸Î¡A ¦¬¦¨ !¡§ªºªO¤W´£¨ÑªºThera ^¤å³ø§i, ¨ä¤¤¤S¥HCIBC 2017/4/19 ¨º¥÷µ¹¤F§Ú³Ì¦h±Òµo, ¥ß°¨¤WThera ºô¯¸«Å¥¨ä3/1ªº investor webcast (www.theratech.com/en/content/theratechnologies-host-investment-community-webcast-march-1-2017), webcast ªº¸ê®ÆÀÉ ¡]½Ð¦Û¦æ¤U¸ü¡^¤¤¦³¸Ô²Óªº355 ¤W¥««e¥«³õ¤ÀªR (¨ü³X¹ï¶HÀ³¬OHIV±MªùÂå¥Í, À³¸Ó«Ü¦³°Ñ¦Ò©Ê), ¦A¥[¤W¹L¥h¥b¦~2«×°Ñ¥[°õ¦æªø¥D«ùªº·|ijµ§°O, ¤U±¦³´XÓ«ÂI¤À¨É¤@¤U, ³Ñ¤U¤£¨¬ªº´N½Ð¦U¦ì¦Û¦æ¥h«õÄ_¤F¡K 1. ÃÄ»ù¡GThera ±q¤½¨p¬ÛÃö³¡ªù ( ³ø§i¤¤¥ÎPayer, À³«ü«OÀIÅé¨t)Àò±oªº¦^õXÅã¥Ü¥X¨C¦~7~10¸U¬üª÷ªºÃÄ»ù¬O¥i¥H±µ¨üªº. 2. ¥«³õº¯³zA¡G¦b¦ôpªº20-25k MDR¯f¤H¤¤ 50-56% ªº¯f¤H¤w±Á{»Ýn´«ÃĪº¶¥¬q¥BÂå¥Í¤wªí©úÄ@·N¨Ï¥Î355. 3. ¥«³õº¯³zB: 355¤@¥¹¤W¥«·|³Q¯Ç¤JMDR ªvÀøguidline ¤¤¥B¤]·|³Qµø¬° Medicae PartB (¤£¬O¤Óª¾¹D¨ä·N¸q, ¦ý¬O¤å¤¤«ü¥X«OÀI³æ¦ì±NÃø¥H©Úµ´¤ä¥I¦¹ÃÄ) 4. ÃÄÃÒ¼f¬d¡G¤j¦h¹w´ÁHIVÃĹL¥h´XÓªº¼f¬d®É¶¡¤£¶W¹L6Ó¤ë, 355¥H¨ä¬ð¯}©ÊªvÀø¡Ï©t¨àÃĪºª¬ªpThera. webcast ¤¤Áô¬ù´£¨ì¦³¾÷·|´£¦¼Æ¶g¨úÃÒ 5. ¬d¼t¡GCIBC´£¨ì Thera guide ¤ÀªR®v6/7¤ë·|¬d¼t, ¦ý¬OFDA§Æ±æ´£«e¤@ÂI, ©Ò¥H5/6¤ë¤]¦³¥i¯à. ¦A¤ñ¹ïªáºX»P·ç¤h«H¶Uªº³ø§i¡K..§Ú·Q2018¤¤¸Î¶}©lÁÈ¿úªº¾÷·|À³¸Ó·¥¤j. ¥[¤Wwebcast ¸ê®Æ²Ä40¶¤¤Åã¥Ü¾ú¥v¤W¦¨¥\ªºHIV¥ÎÃÄ¥§¡²Ä4¦~¹Fpeak sales. ¬Ý¨Ó¤¤¸Î±N¬O¬~¨ê·sÃĤ½¥q³£¬OÁ«·l³fªº¦Ã¦Wªº»âÀY¦Ï. ¦]¥»ºôºûרt²Î¡A¸ê®Æ«ì´_¨ìµy¦®Éªº°O¿ý¡A¬G³y¦¨Ó¤H¯d¨¥³Q®ø°£¡A³y¦¨¤£«KÁٽШ£½Ì¡C BY¥²´Iºôª©¥D
|
|
·|û¡G¶³²H·»´10146472 µoªí®É¶¡:2018/11/1 ¤U¤È 04:19:08²Ä 4142 ½g¦^À³
|
ɨé¾lÃB: 12046 ɨé½æ¥X¾lÃB: 11273 ½æ¥X²v 93.5% |
|
|
·|û¡Gvito10147056 µoªí®É¶¡:2018/11/1 ¤U¤È 04:02:59²Ä 4141 ½g¦^À³
|
¾Ú§Ú©Òª¾ Éú³¤£¤@©w¦³½æ¥X, ¦³¥i¯à¥ª¤âÉú³µ¹¥k¤â |
|
|
·|û¡G¶³²H·»´10146472 µoªí®É¶¡:2018/11/1 ¤U¤È 03:53:50²Ä 4140 ½g¦^À³
|
¦h©Û¤@¨Ç©Ð«È§a~~ ¤]³\©u³ø¤½§G¬O¤@ÓÂI~~ |
|
|
·|û¡G¸ºñ¯À10147750 µoªí®É¶¡:2018/11/1 ¤U¤È 03:06:55²Ä 4139 ½g¦^À³
|
10¤ë31¤é¤î¤¤¸Îɨ÷½æ¥X¹F11273±i¡AªÑ»ù¦bªø´ÁÀV³¡ªþªñ¡A¾Þ½LªÌ¨ì©³¦bª±þ©Û? |
|
|
·|û¡GÀH½t¦Û¦b10147011 µoªí®É¶¡:2018/11/1 ¤W¤È 07:15:03²Ä 4138 ½g¦^À³
|
THªÑ»ù 10¤ë22¤é½L¤¤³Ì§C6.72 ¦¬½L7.11 10¤ë31¤é¦¬½L8.54 |
|
|
·|û¡G¤ßºC10141111 µoªí®É¶¡:2018/10/31 ¤U¤È 10:56:57²Ä 4137 ½g¦^À³
|
§Ç¸¹ 2 µo¨¥¤é´Á 107/10/31 µo¨¥®É¶¡ 22:48:28 µo¨¥¤H ±i©Àì µo¨¥¤H¾ºÙ ¸³¨ÆªøÝ°õ¦æªø µo¨¥¤H¹q¸Ü (02)26580058 ¥D¦® ¤½§iTMB-355(TROGARZO)Á{§É¤T´Á¤ÀªRµ²ªG¦b®æ©Ô ´µô2018¦~·R´þ¯fÃĪ«ªvÀø¬ã°Q·|late-breaker³õ¦¸ µoªí¤fÀY³ø§i ²Å¦X±ø´Ú ¡@²Ä 53 ´Ú ¨Æ¹êµo¥Í¤é 107/10/31 »¡©ú 1.¨Æ¹êµo¥Í¤é:107/10/31 2.¤½¥q¦WºÙ:¤¤¸Î·sÃÄ 3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q):¥»¤½¥q 4.¬Û¤¬«ùªÑ¤ñ¨Ò:¤£¾A¥Î 5.µo¥Í½t¥Ñ: ¤¤¸Î·sÃĤ½§iTrogarzo(ibalizumab-uiyk)Á{§É¤T´Á¸ÕÅç³Ì·sªº¤ÀªRµ²ªG¤w©ó¤µ¤é¦b®æ©Ô ´µô2018¦~·R´þ¯fÃĪ«ªvÀø¬ã°Q·| (HIV Drug Therapy Glasgow 2018) late-breaker³õ ¦¸µoªí¤fÀY³ø§i¡C ¤§«eÁ{§É¤T´Á¼Ï¯Ã¸ÕÅç®É¬O¥H¡¨·N¹ÏªvÀø-¯Ê¤Ö§Y¥¢±Ñ¡¨ (intent-to-treat¡Vmissing equals failure, ITT-MEF)ªº¤èªk¤ÀªR¡A¹ï©ó¨S¦³§¹¦¨¸ÕÅ窺¯f±w¡A¤£½×ì¦]¬Òµø¬°ªv Àø¥¢±Ñ¡A¬O¬Û·í«O¦uªº¤ÀªR¤è¦¡¡C³o¦¸«h¬O°w¹ï¤w§¹¦¨¸ÕÅ窺¯f±w¤ñ¸û¨Ï¥ÎITT-MEF¤è ªkªº®t²§¡C 40¦ì¯f±w¤¤¦³31¦ì¦b²Ä25¶g¤´¦b¨Ï¥ÎTrogarzo¡A¥L̪º¯f¬r°§C¶q¤¤¦ì¼Æ¬O2.5 log10 (¯f¬r¶q¤U°99.7%)¡A¨ä¤¤17¦ì¯f±w(55%)ªº¯f¬r¶q§C©ó50 copies/mL¡CY¨Ï¥ÎITT-MEF ¤èªk¤ÀªR¡Aµ²ªG¬°¯f¬r¶q¤U°1.8 log10 (¯f¬r¶q¤U°98.4%)¡A43%ªº¯f±w¯f¬r¶q§C©ó 50 copies/mL¡C ¦b²Ä48¶g®É¡A24¦ì¯f±w¤´¦³¨Ï¥ÎTrogarzo¡A¯f¬r°§C¶q¤¤¦ì¼Æ¬O2.9 log10 (¯f¬r¶q¤U °99.9%)¡A¨ä¤¤16¦ì¯f±w(67%)ªº¯f¬r¶q§C©ó50 copies/mL¡CY¨Ï¥ÎITT-MEF¤èªk¤ÀªR¡A µ²ªG¬°¯f¬r¶q¤U°2.8 log10(¯f¬r¶q¤U°99.8%)¡A59%ªº¯f±w¯f¬r¶q§C©ó50 copies/mL 6.¦]À³±¹¬I:µL 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ: ·sÃĶ}µo®Éµ{ªø¡B§ë¤J¸g¶O°ª¥B¥¼«OÃÒ¤@©w¯à¦¨¥\¡A¦¹µ¥¥i¯à¨Ï§ë¸ê±Á{·ÀI¡A §ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C ¥»¦¸«¤j°T®§»P¥»¤½¥qTMB-355¦æ¾P¹Ù¦ñTheratechnology¤½¥q¦P®É«¤j°T®§µo§G¡C |
|
|
·|û¡GDHL10147526 µoªí®É¶¡:2018/10/31 ¤U¤È 08:58:04²Ä 4136 ½g¦^À³
|
°ê®õ¥Á¦w¤j¡A¬ü°êonly, ¬ü°ê¤@¦~HIV¦³2xxxµLÃÄ¥iÂå¡A4¦~¤j¬ù8xxx¤H¡A¦A¼¤Wfailure rate,¤j¬ù´N¬O³o¼Ë¼Æ¦r. |
|
|
·|û¡GÀH½t¦Û¦b10147011 µoªí®É¶¡:2018/10/31 ¤U¤È 06:04:41²Ä 4135 ½g¦^À³
|
¥~¸ê¤j´T½æ¶W¡A¹ï©óÄw½Xªº¦w©w©Ê¡A ªº½T³y¦¨¼vÅT¡I º¯³z²v½w¨B¤W´¤~¬O¤ý¹D¡I °²¦p2021¬Oº}«Gªº°±§Q¦~¡A ¨ä¾lªº¤zÂZ¦]¯À³£¬Oµu¼Èªº¡I |
|
|
·|û¡G¸ô¤H¥Ò10135334 µoªí®É¶¡:2018/10/31 ¤U¤È 05:29:18²Ä 4134 ½g¦^À³
|
¥u¯àµ¥¤F... À禬¬°¤ý, ¨S¦³«G²´ªºÀ禬, ¥~¸ê«ÜÃø¦^ÀYªº ¦³«G²´ªºÀ禬, ¬ü¤¸¦A±j¤]±j¤£¹L¦hÀYº¦¶Õ (¦ý«G²´ªºÀ禬¾÷²v¤Ó¤p) §Ö¶}¼ú¤F... «ø¥Ø¥H«Ý... |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/31 ¤U¤È 05:02:52²Ä 4133 ½g¦^À³
|
¨ä¹ê¦³¨Ç®ÉÔµu¤¤½u¤W¡A¥~¸êªº¶R½æ¶W¡A¹ïªÑ»ù¤è¦V¡A¨Ã<<°_¤£¤F>>¨M©w©Êªº§@¥Î §Ú¦³Æ[¹î¨ì 4162 ¤§«e¥~¸ê¤@ª½¦³¶R¶W¡A¦ýªÑ»ù«o¶^¶^¤£¥ð¡A©Ò¥H¦³®É¥h¬Ý¥L̪ºµu½u¶i¥X·|ºN¤£µÛÀYºü¡A¬Æ¦Ü§A·|³Q»~¾É³Q¤Ú¨Ó¤Ú¥h ¦ý§Ú¨S§_»{¦U¬n¸ê¹ï©ó 4147 ªº½T¬O¤@ª½¤@¸ô³s½æ¡A¤£ÃP¤â¡A³oªº½T¬Oȱo¤j®a±K¤ÁÃöª`... ¶È¨Ñ°Ñ¦Ò |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/31 ¤U¤È 04:46:06²Ä 4132 ½g¦^À³
|
©Ò¥H³o¨Ç¥~¸ê¬O¯uªºn¶}©l K ¶Ü¡H ÁÙ¬O¬ü¤¸¤Ó±j¡AµL½×¦p¦ó³£¬O´î½X¡þÁ×ÀI¥xªÑ¡A§â¸êª÷©â¨« ȱoÆ[¹î... |
|
|
·|û¡Gvito10147056 µoªí®É¶¡:2018/10/31 ¤U¤È 04:25:00²Ä 4131 ½g¦^À³
|
¥~¸ê½æ¶W879±i |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/31 ¤U¤È 01:55:58²Ä 4130 ½g¦^À³
|
fnc.ebc.net.tw/FncNews/Content/57289?from=webpush 8¦~¿N150»õGogoro¦¨¹q°Ê¨®ÀsÀY ³°¾Ç´ËÃn¶Q¤H¬O¥L ÁöµMµLÃö¡A§Ú¦Û¤v¹ï¥úÀY¤]¨S¦³¦n´c¡A¯Âºé¬O¤Þ¤@¤UÃD¡A ¬Y¨Ç²£·~¡A¯uªº¬On¦³¤@ªÑ®ð¦b¡A¤~¼µ±o¤U¥h¡A¥i¥H¬Ý¨ìÀG¹DºÉÀY¡A¦ý¥xªÑ¯uªº¬O¤Ó¹L²L¡A¤Ó±`³QÄw½X¡þ±¡ºü±±aµÛ¨«... |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/31 ¤U¤È 01:42:46²Ä 4129 ½g¦^À³
|
·íµM§Ú¤F¸Ñ¤j®a¤ß²z¤WªºÃø³B¡A»sÃĥͧޯuªº¬O«¼C¤j´£¨ìªº¡A³Ì³Ì°ª·ÀI³ø¹Sªº±Ú¸s ¥xªÑ´N¬O³o¼Ë¡Aº¦¶Wº¦¡A¶^¶W¶^.... °È¥²«ù¬Õ«O®õ¡A¥ý¨Dð·.... |
|
|
·|û¡G¶³²H·»´10146472 µoªí®É¶¡:2018/10/31 ¤U¤È 01:33:34²Ä 4128 ½g¦^À³
|
FYI. www.genetinfo.com/investment/featured/item/20948.html G940¤j, ¤F¸Ñ, ·PÁÂ! |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/31 ¤U¤È 01:22:29²Ä 4127 ½g¦^À³
|
¶³¤j¡A§Úı±oÀ禬¤½¥¬«e³Ì¦n¥«³õ¤£n¥ý¦³¼ÖÆ[±¡ºü<<©Î³\>>¤ñ¸û¦n¡AÁקK¤S¦³¥¢±æ©Ê½æÀ£¡A³y¦¨nªø½u¾ã²z§ó¤[ ¦pÂy¤j¦b¥t¤@¸s»¡ªº==>¯uªº©^ÄU¤j®a¡A¡u«Dªø²ö¤J¡v¡A¡u¥Ã¤£°l°ª¡v¡I »sÃĥͧުº±±½LªÌ¡A¤]¬O¬Û·íµR§Q¡A¯uªº¨Ã¤£®e©ö¾Þ§@¡A»Ýn°ö¾i@¤ß»P«H©À XD ¦@«j... |
|
|
·|û¡G°ê®õ¥Á¦w10141426 µoªí®É¶¡:2018/10/31 ¤U¤È 12:47:35²Ä 4126 ½g¦^À³
|
DHL¤j¡A½Ð°Ý±zªº4¦~«á¬ù¦³7¤d¦Ü8¤d¤H¬O§_§t¼Ú¬w©O? |
|
|
·|û¡G¶³²H·»´10146472 µoªí®É¶¡:2018/10/31 ¤W¤È 11:52:52²Ä 4125 ½g¦^À³
|
¤µ¤éªº¨«¶Õ~~ªí¥Ü¹ï10¤ëÀ禬§¹¥þ¨S¦³´Á«Ý? ¤Àɱ¾¶Rªº¤ñ¸û¦h¤@ÂI, Y¬O°²³æ? ´N¬O»¤¦h? |
|
|
·|û¡GRosetta10146840 µoªí®É¶¡:2018/10/31 ¤W¤È 12:01:59²Ä 4124 ½g¦^À³
|
¬ü°ê©x¤è½Ã¥Í³æ¦ì¡AÀ³¸Ó¤]¬Oµ¥¨ì¦¹µ²ªG¥X¨Ó«á¡A¤~´±I®Ñ~ ¥i±¤¥d¦b¤jÀô¹Ò¤U¡AªÑ»ùÀ³¸Ó¬Oº¦¤£¤W¨Ó¡ã´«Ó¨¤«×·Q¡A¥i¯à¬O§G§½ªº¦n¾÷·|¡ã¡I |
|
|
·|û¡Gªü¤¤10143502 µoªí®É¶¡:2018/10/30 ¤U¤È 10:13:04²Ä 4123 ½g¦^À³
|
§ó¥¿¬O7¤é«D7©P |
|
|
·|û¡Gªü¤¤10143502 µoªí®É¶¡:2018/10/30 ¤U¤È 10:08:44²Ä 4122 ½g¦^À³
|
è¬Ý¤@¤UTH°Q½×ª© ¤½¥qªº·s»D½ZÀ³¸Ó¦³»~ À³¸Ó¬O7©P«D7¤é |
|
|
·|û¡GDHL10147526 µoªí®É¶¡:2018/10/30 ¤U¤È 10:08:35²Ä 4121 ½g¦^À³
|
¥H³o¼Ëªºfailure rate,¬Ý¨Ó4¦~«á¡A¨Ï¥Î¤H¼Æ7000-8000¤H¡AÀ³¸Ó·U¨Ó·U¾aÃСC |
|
|
·|û¡G¤ßºC10141111 µoªí®É¶¡:2018/10/30 ¤U¤È 08:27:05²Ä 4120 ½g¦^À³
|
¤½§iTMB-355(TROGARZO)Á{§É¤T´Á¤ÀªRµ²ªGµoªí¦b®æ©Ô´µô Á|¿ìªº2018¦~·R´þ¯fÃĪ«ªvÀø¬ã°Q·|¡A»¡©úÃÄ«á7¤é¥¼¹F¥DnÀø ®Ä«ü¼Ðªº¯f±w©ó¸ÕÅçµ²§ô®ÉÅã¥ÜTROGARZO¨ã¦³Á{§É¯q³B 20:11 µo§G®É¶¡: 2018/10/30 20:11 ì©l¨Ó·½ 1.¨Æ¹êµo¥Í¤é 107/10/30 2.¤½¥q¦WºÙ ¤¤¸Î·sÃÄ 3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q) ¥»¤½¥q 5.µo¥Í½t¥Ñ ¤¤¸Î·sÃĤµ¤é¤½§iTrogarzo(ibalizumab-uiyk)Á{§É¤T´Á¸ÕÅçµ²ªGÅã¥Üµ¹¤©°_©l¾¯¶q7¤é«á¡A¥¼¹F¥DnÀø®Ä«ü¼Ð (¯f¬r¶q°§C ? 0.5 log10 ;§Y¯f¬r¶q¤U°?68%)ªº¯f±w¡A³Ì²×¦b¸ÕÅç´Á¶¡Å㤴Àò±oTrogarzoªºÁ{§É¯q³B¡C40¦ìÁ{§É¤T´Á¸ÕÅç¯f±w¤¤¡A¥u¦³7¦ì¥¼¹F¨ì¥DnÀø®Ä«ü¼Ð¡C¦b®æ©Ô´µôÁ|¿ìªº2018¦~·R´þ¯fÃĪ«ªvÀø¬ã°Q·| (HIV Drug Therapy Glasgow 2018)µoªí³o7¦ì¯f±wªºµ²ªG¡A¦b¨Ö¥Î³Ì¾AI´ºÀøªk(OBR)«á¡A¨ä¤¤3¦ì¦b²Ä25¶gªº¯f¬r¶q§C©ó50 copies/mL©Î¬O§C©ó°»´ú½d³ò¡A1¦ì¦b²Ä25¶g®É¯f¬r¶q¤U°1.1 log10 (¯f¬r¶q¤U°92%)¡A2¦ì¦b²Ä21¶g®É¯f¬r¶q¤À§O°§C2.1¤Î1.6 log10 (¯f¬r¶q¤U°99.2%¤Î97%)¡A°ß¤@¤@¦ì¥¼§¹¦¨¸ÕÅ窺¦b²Ä21¤Ñ®É¯f¬r¶q¤U°¹F0.5 log10 (¯f¬r¶q¤U°68%)¡C³o¨Çµ²ªG§ó¥[Åã¥ÜTrogarzo¥i¥H¦³®Ä°§CµL¤Ó¦hªvÀø¤è®×¿ï¾Üªº¯f±wªº¯f¬r¶q¡A¦Ó³o¤]³Q§ó·s©ó¬ü°ê½Ã¥Í¤Î¤½¦@ªA°È³¡ (DHHS)¤½¥¬ªº·R´þ¥ÎÃÄ«ü«n¡C 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ ·sÃĶ}µo®Éµ{ªø¡B§ë¤J¸g¶O°ª¥B¥¼«OÃÒ¤@©w¯à¦¨¥\¡A¦¹µ¥¥i¯à¨Ï§ë¸ê±Á{·ÀI¡A§ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C¥»¦¸«¤j°T®§»P¥»¤½¥qTMB-355¦æ¾P¹Ù¦ñTheratechnology¤½¥q¦P®É«¤j°T®§µo§G¡C |
|
|
·|û¡G¶³²H·»´10146472 µoªí®É¶¡:2018/10/29 ¤U¤È 10:47:05²Ä 4119 ½g¦^À³
|
¨é½æ¼W¤£°±¡AªÑ»ùÃø¦³ªí²{¡C ¦P¼Ëªº¨Æ¥ó¡ATH¥Ø«e¼Q¼Q¼Q⋯ 4147¤S¬O¶}°ª¨«§C⋯ |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/29 ¤U¤È 09:54:17²Ä 4118 ½g¦^À³
|
¬n¸ê¤µ¦~Á`¦@³Ì°ª®É®w¦s¹F5¸U±i ¤§«á¦]¬°º¯³z²vªì´Á¤£¦p¹w´Á¡A°£¤F«á¨Ó¶Rªº³¡¥÷¡A´X¥G¥þ³¡¥ý¥X±¼¤§¥~¡A¥t¥~¶^¯} 250 ¤W¤U®É¡A ¤@¸ô«Ø¥ßɨ÷Á×ÀI¨ä¥¦ 4 ¸U±i³Ñ¾l®w¦s ©Ò¥H·PıÁ×ÀI¤ßºA¬Û·í¿@«p¡A¦ý«o©|¥¼¤@¸ô¬å®w¦s§âªÑ»ù¬å¦º¡A¦]¬°¬å¤U¥h«Ü¦h³£¬O¦Û¤vªº¦× ¥i¯à¤j¥~¸êªº¾Þ§@´N¬O³o¼Ë¡A¦]¬°¸êª÷°÷¤j¡A©Ò¥H¥i¥H¤Ï¦V°µÁ×ÀI³æ¡A ¤]¥Nªí¯uªºn®³¥X¨¬°÷ªø´Á·~ÁZ»¡ªA¤H®aÄ@·N¦^¸É ɨ÷Ó¤HÆ[¹î¡A¶È¨Ñ°Ñ¦Ò |
|
|
·|û¡Ghcs31810146781 µoªí®É¶¡:2018/10/28 ¤U¤È 10:39:20²Ä 4117 ½g¦^À³
|
¤@¬q®É¶¡¨S¤W¨Ó¤F¡A ÁÙ¬On®¥³ß¤¤¸Î¡A¥¿¤@¨B¤@¨B©¹¦nªº¤è¦V«e¶i¡A §ë¸ê·sÃĬO»Ýn@¤ßªº¡A ³Ìªñ¤S¹J¨ì°ê»Ú§½¶Õ¤£Ã¡A ¬J¨Ï¦³¦n®ø®§¡A §Ú·Q¹ïªÑ»ùÁÙ¬OÀ°§U¦³¡A ÁÙ¬O¨CÓ¤ë¨CӤ몺À˵øÀ禬¥H¤ÎÃöª`«á±TMB 607/365/Bispecificµ¥·sÃĪºµo®iª¬ªp¬O¤ñ¸û¹ê»Úªº¡A §Æ±æ°í«ù¨ì³Ì«áªº¤H¬OĹ®a... |
|
|
·|û¡GÂyªÌ10142287 µoªí®É¶¡:2018/10/28 ¤U¤È 09:35:24²Ä 4116 ½g¦^À³
|
¦ü¥G¦b¤µ¦~7¤ë25¤é®É¡A¤]¦³¤@«hÃþ¦üªº°T®§¡A ¬d¤@¤U¡Aì¨Ó·í®É¬O³Q¡u°ê»Ú§Ü¯f¬r¨ó·|-¬ü°ê¤À·|¡v¡A ¦C¤J³Ì·sª©ªºªvÀø«ü«n¡A ÄÝ¡u¥Á¶¡¡vÂåÀø¨ó§Uªº±ÀÂË¡A ¦Ó³o¦¸¡A¬O¦b¤¤¸ÎÃĪ«®Öã¤W¥«¨Ï¥Îªñ¥b¦~¤F¡A¬ü°ê衞ºÖ³¡¤~ ¥¿¦¡¦C¤J¡u©x¤è¡vªº¬ü°ê½ÃºÖ³¡·R´þ¯fªvÀø«ü«n¡A ·Q¥²¦b¸g¹LFDA®Öã¤W¥«¨Ï¥Î«á¡A¬ü°ê½ÃºÖ³¡©x¤è¦b¸g¹L¯f±w¥ÎÃĪñ ¥b¦~ªºÆ[¹î¡A±o¨ì¤@¨ÇÂåÀø¸ê°T¡A¤~¡u©ñ¤ß¡v¦C¤J©x¤èÂåÀø«ü«n¡A ¡u¥Á¶¡¹ÎÅé¡vªº±ÀÂˤΡu¥¿¦¡©x¤è¡vªº»{¥i¡A±E»´±E«⋯, ¦b¶Ç¼½¼s§i®ÄªG¤Î¼W±jÂå¥Í¡B¯f±w¹ï¤¤¸ÎªºTMB355·sÃĪº¨Ï¥Î«H¤ß¡A ³o¦ü¥G¤]§ó¥[Åã¥Ü¤¤¸Î¤½¥q¡A¦b¤µ¦~6¤ë¥÷ªÑªF¤j·|¤¤¤Î«áÄòªºªk»¡·| ¤º®e¡A¤@ª½°í«ùµÛ¡A¦Û¤µ¦~11¤ë¥÷°_ªº¡u¾P°â¦¨ÁZ¡v¤Î¨Ï¥ÎÃĪ«¯f±w¼W¥[¼Æ¡A ·|Åý§ë¸êªÌ¦³·P¡A¦p¤µ¬Ý°_¨Ó¡A¤@¦p¬J©¹¡A¥i«H«×¤£ÅÜ¡I ¦Ü©ó±q11¤ë°_ªº¾P°â¦¨ÁZ¼W¥[·|¨ì¤°»òµ{«×¡A ¦Aµ¥60´X¤Ñ¡A¹L¤F2019¦~1¤ë5¤é«e¡A´Nª¾¹D10¤ë¡B11¤ë¡B12¤ëÀ禬¤F¡A ©¡®É¡uÁͶաv´N¤ñ¸û²M·¡¤F¡A ¥´Ây ªº¡A¬O«ù¥±`¤ß¬Ý«Ý¡A ¤£¹L¦p¯à¹³¡uDHL¡v¤jªº¦W¦r¡A ¨º»ò§Ö³t¡A¹ÀåFÃaªº^_^ |
|
|
·|û¡GDHL10147526 µoªí®É¶¡:2018/10/28 ¤U¤È 08:55:28²Ä 4115 ½g¦^À³
|
³o¼ËÀ³¸Óºâ¤j§Q¦h§a¡I¤õ½b¥¿©¹¤ÓªÅ«e¶i¡A§Y¨Ï¦a¤ß¤Þ¤OÁ٫ܤj¡C |
|
|
·|û¡G¹Íªi10139990 µoªí®É¶¡:2018/10/28 ¤U¤È 03:57:44²Ä 4114 ½g¦^À³
|
¡i¤½§i¡j¤¤¸Î·sÃÄ·R´þ¯f·sÃÄTrogarzo³Q¥[¤J¬ü°ê·R´þ¯fªvÀø«ü«n 2018/10/28 15:02:11 ¡]¤¤¥¡ªÀ2018¦~10¤ë28¤é¹q¡^ ¤é¡@¡@´Á¡G2018¦~10¤ë28¤é ¤½¥q¦WºÙ¡G¤¤¸Î·sÃÄ(4147) ¥D¡@¡@¦®¡G¤¤¸Î·sÃÄ·R´þ¯f·sÃÄTrogarzo³Q¥[¤J¬ü°ê·R´þ¯fªvÀø«ü«n µo¨¥¤H¡G±i©Àì »¡¡@¡@©ú¡G 1.¨Æ¹êµo¥Í¤é:107/10/28 2.¤½¥q¦WºÙ:¤¤¸Î·sÃĪѥ÷¦³¤½¥q 3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q):¥»¤½¥q 4.¬Û¤¬«ùªÑ¤ñ¨Ò:¤£¾A¥Î 5.µo¥Í½t¥Ñ: ¬ü°ê½ÃºÖ³¡(DHHS)©ó10¤ë25¤é§ó·s¨ä·R´þ¯fÃĪ«¨Ï¥Î«ü«n¡C¤å¤¤¯S§O´£¨ì¡G¡u¹ï©ó¦b ¦å²G¤¤¤´¥iÀË´ú¨ì·R´þ¯f¬r¡A¥B¯Ê¥F§¹¾ãªº¦³®ÄÃĪ«²Õ¦X¿ï¾Üªº¯f±w¡A¥i¨Ï¥Îªñ´Á®Ö ã¤W¥«ªºTrogarzo¡C¡v Trogarzo¨Ã³Q»{¥i¾Ö¦³¯S§Oªº§@¥Î¾÷¨î¡C Trogarzo¦b¬ü°ê¤w¸g¤W¥«¥b¦~¡A³Q¦C¤JDHHSªº·R´þ¯fªvÀø«ü«n¡A±N¦³§U©óTrogarzoªº ¼sªx±Ä¥Î¡C 6.¦]À³±¹¬I:µL 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:·sÃĶ}µo®Éµ{ªø¡B§ë¤J¸g¶O°ª¥B¥¼«OÃÒ¤@©w¯à¦¨¥\¡A¦¹µ¥¥i¯à¨Ï§ë ¸ê±Á{·ÀI¡A§ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C |
|
|
·|û¡G¹A¤Ò10147224 µoªí®É¶¡:2018/10/28 ¤U¤È 01:01:44²Ä 4113 ½g¦^À³
|
¤Uª`ÃB¶·¥H¦Û¤v¯à©Ó¨üªº·ÀI¬°¡A¤Á¤£¥i¥u¬Ý¨ì¥i¯àªº§Q¯q¡A©¿²¤¼ç¦bªº·l¥¢ Ä´¦p¡A¥H©Ð¶U´Ú¤Uª`ªÌ¡A·ÀI©Ó¨ü¯à¤O´N¤ñ¤@¯ë¤Hn§C¡A¤Uª`ÃB´N¤£¥i¤Ó°ª Y¬Ý¿ù·l¥¢ª÷ÃB¡A¤£¤Ó¼vÅT¦Û¤v¤Î®a®x¥¼¨Ó¡AÀ³´N¥i¨Ì·Ó·N¦V¤Uª` ¨CÓ¤H©Ó¨ü·ÀIªº¯à¤O¬Ò¤£¦P |
|
|
·|û¡G¹A¤Ò10147224 µoªí®É¶¡:2018/10/28 ¤U¤È 12:44:36²Ä 4112 ½g¦^À³
|
©ã©Î¤£©ã«ª`¡AÀ³¸ÓÀu¥ý¦Ò¼{ªº¬O·ÀI«Y¼Æªº°ª§C¡A¥H¤Î¦Û¤v¬Æ¦Ü®a®x©Ó¨ü¸Ó·ÀI«Y¼Æªº¯à¤O¬°¦ó¡H |
|
|
·|û¡G¹A¤Ò10147224 µoªí®É¶¡:2018/10/27 ¤U¤È 11:49:10²Ä 4111 ½g¦^À³
|
¾ú¥vªº¸gÅç¡G2015.02 TMB-355Àò±o¬ð¯}©ÊÀøªk¸ê®æ¡A¦ý2015.Q3¶^¦Ü¦Ê¤¸¥H¤U ©Î³\¸Ó«ä¦Ò¡A¨SÁȨì¹ï¦Û¤vªº¼vÅT¬°¦ó¡H¶^»ù·l¥¢¹ï¦Û¤vªº¼vÅT¬°¦ó¡H §Q®`Ãö«YÁר䫡A¨ú¨ä»´§a¡H ³o¼Ë¤]³\´Nª¾¦p¦ó¨ú±Ë§a¡H©Î½Õ¾ã§a¡H |
|
|
·|û¡GRosetta10146840 µoªí®É¶¡:2018/10/27 ¤W¤È 01:11:00²Ä 4110 ½g¦^À³
|
·PÁÂmengs »PG940 ¤j¹ï©ó¤p§Ìªºµ¦²¤´£¥Xµû½×¡ã ¥Ø«e§ÚÁÙ¨S¹ê¬I¡A³´¤Jªø¦Ò¤¤(³o¤äªÑ²¼¡A¥i¯à¤]°]´I½Â઺¤@Ó«´¾÷¡A©Î¬O°]²£¸y±Ù)... ¤£¹L³o¨â¶g¥xªÑªºªí²{¡ã§Ú̯uªºn¤ß¦s·q¬È¡A¤]¨£ÃѨì²LºÐ¥«³õªº«H¤ß«×»P¬F©²¤z¹w¥«³õ¦Ó¼W¥[¤F§ë¸êªºÂø°T... ¤UÓ¤ë¦pªG¯uªº¦b¥x®ü¶i¦æxºt... ¦ôÓ5100 |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/26 ¤U¤È 09:06:16²Ä 4109 ½g¦^À³
|
¥xªÑªñ´Á³sÄò¯}©³ªºÓªÑ¡A¦h¤£³Ó¼Æ¡A¥i¥H»¡¥xªÑ¤w¸g¨ì¤F¨S¦³¥~¸ê¬¡¤ô´N¬¡¤£¤U¥h¡A´N¦³ÄY«¬y°Ê©Ê·ÀIªº°ÝÃDµo¥Í ³\¦hӪѡA¤w¸g¯uªºµLªk¦A¥Î¥ô¦ó»ùȨӵû¦ô¡A¤§«e¶R¶i¡Aµu´Á¨S¦³§Q¦h¤ä¼µ¡A´NÄw½X¤@ª½¤@¸ô°±·l¡A¥þ³¡³£¬O³sÀô±þ ¦]¬°¦³¤£½T©w©Ê¦b¡A¨S¤Hª¾¹D¨â°¦¤j¶H°«¨ì¦ó®É¡AÁÙ¦³¬üªÑ¬O§_¤w¸g¯uªº¨ì³» ¥u¯à»¡¥xªÑ«H¤ß¤Ó¹L¯Ü®z¡A¹ï©ó¤@¯ë§ë¸ê¤H´²¤á¦Ó¨¥¡A¯uªº¬O¬Û·í¤£®e©ö§@ªø´ÁªºªÑ¥«¡A°£«D³£¬O¯à·Ç½T§ì¨ì¬Û¹ï°ª¡A¬Û¹ï§CÂI¡A¥Î®É¶¡¨ÓÀ³¹ïªº§ë¸ê¤H¡A¤~¥i¯à¦³¦nªø´ÁÁZ®Ä¡A¤£µM´N¬O§Þ³N±¬Û·í±j ¹ï³oӪѥ«¡A¯uªºn¤ß¦s·q¬È... |
|
|
·|û¡Gvito10147056 µoªí®É¶¡:2018/10/26 ¤U¤È 01:36:13²Ä 4108 ½g¦^À³
|
5500-6000¤§¶¡ |
|
|
·|û¡G§õ©úÛ10147725 µoªí®É¶¡:2018/10/26 ¤W¤È 08:27:57²Ä 4107 ½g¦^À³
|
731¸U-1301¸U-2330¸U-3701¸U ¤ë¼W600¸U-1000¸U-1400¸U ¦±½u¤£ÅÜ´N¬O1800¸U=5500¸U 5500¸U¥H¤W´N¬O§Q¦h¡A¦±½u¶}©l¦³¤W´ªº¸ñ¶H¡C |
|
|
·|û¡GUncle Albert10146736 µoªí®É¶¡:2018/10/25 ¤U¤È 10:36:07²Ä 4106 ½g¦^À³
|
5400 |
|
|
·|û¡G³¥¯«¨ë«È10147531 µoªí®É¶¡:2018/10/25 ¤U¤È 08:12:47²Ä 4105 ½g¦^À³
|
5500 |
|
|
·|û¡G561910141205 µoªí®É¶¡:2018/10/25 ¤U¤È 07:41:03²Ä 4104 ½g¦^À³
|
5400 |
|
|
·|û¡GNick10147288 µoªí®É¶¡:2018/10/25 ¤U¤È 07:12:44²Ä 4103 ½g¦^À³
|
²q·Q10¤ëÀ禬 6000¸U¥ª¥k ¦ýÓ¤HÁÙ¬Oı±o4147¨Ã¤£¤Óºâ¬OªÑ¨a¬Û¹ïéw ¦Ó¬O¤§«e´N¤w¸g£¸¸ô¶^¦n¤@°}¤l¤FQQ ¦Ë¥_¼t »ö¾¹³]³Æ ¦w¸Ë/½T®Õ 3Q2018¡V1Q2019 »sµ{¾É¤J¤Î §Þ³NÂಾ 3Q2018¡V2Q2019 »sµ{ÅçÃÒ 2H/2019 12Ó¤ëÃÄ«~ ¦w©w©Ê½T»{ FDA ¬d¼t 3Q2019-4Q2020 °Ó·~¥Í²£ ¨Ó·½ 2018/09/19 ¤¸¤jÃҨ黴䤽¥qÁ|¿ì¤§¨È¬w¥Í§Þ§ë¸ê½×¾Â PDF |
|
|
·|û¡Gmengs10146592 µoªí®É¶¡:2018/10/25 ¤U¤È 06:55:32²Ä 4102 ½g¦^À³
|
6000 «OÀIÂл\²v¶}©l¤W¨Ó¡ATurboÀ³¸Ón¶Ê¤U¥h¤F¡C 4147¬O§Ú°ß¤@ªº¦h³æ¡A¨ä¥L±q¤K¤ë¶}©l´N¥þ±©ñªÅ¤F ¤£¹LÂб_¤§¤UµL§¹§Z¡A¦pªG»¡±µ¤U¨Ó¬O½L¶^¡A¦³¾÷·|¥i¥H°f¶Õ©¹¤W¡A¦ý¦pªG³£¤@ª½¹³ªñ´Á±þ¤jªº¡A¨º´N¬O¤@°_w¦b¦a¤W¤F |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/25 ¤U¤È 01:43:50²Ä 4101 ½g¦^À³
|
¹J¨ì³oºØÃþ¦üªÑ¨aªº±¡ªp 4147 ¤w¸gºâ«Ü±j¤F¡A8436 ¥»¨¬O·~ÁZ¯uªº¬Û·í¤£¿ùÁÙ¯à°f¶Õº¦¨S¸Ü»¡ ¦ý°ê»Ú±¡¶Õ¡A¨ÌµM¦M¾÷««¡A Ó¤H¤£¬O·Q¬Ýº¦»¡º¦¡A¬Ý¶^»¡¶^¡A¨S¦³¹J¹L´X¦¸ªÑ¨a¡A¯uªº¤]¤£¯à¤F¸Ñ¤°»ò¥s°µ¤H©Ê»P¬ö«ß ´X¥G©Ò¦³¹q¤lÃþªº®i±æ³£¤£ºÉ²z·Q¡A¾¨ºÞ¤w¸g¶^¨ì¤£ª¾¤µ¤i¬O¦ó¤i¡A ¦ý²¦³º¶T©ö¾Ô¡AÁÙ¦³¤§«eªº°ò´Á¡A¥i¯àn§â¿Ä¸ê¥þ³¡±½¥ú§a¡A³o½L©Î³\¤~·|¤î¶^... |
|
|
·|û¡GÀH½t¦Û¦b10147011 µoªí®É¶¡:2018/10/25 ¤U¤È 12:48:34²Ä 4100 ½g¦^À³
|
5000~5500°Ï¶¡ |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/25 ¤U¤È 12:08:56²Ä 4099 ½g¦^À³
|
¥þ²y·ÁnÅb°æ®É¡AÁÙ¬O¦³¥i¥H¤j®a©ñÃP²q²q¬Ýªº®ÉÔ ¤@¤f»ù 5100 ¥ý¨Déw¦¨ªø¡A¤w¸g¤ñ¤j¦h¼Æªº¹q¤lªÑ«á¶Õ¦n¦h¤F |
|
|
·|û¡GMr.C10147720 µoªí®É¶¡:2018/10/25 ¤W¤È 11:53:33²Ä 4098 ½g¦^À³
|
¤ë©³²q²q¼Ö¤S¨ì¤F¡A¥ý²q¥ýĹ¡A²q¤¤¨S¼ú«~¡C §Ú¦ô10¤ë·~ÁZ3,700+1,800=5,500¸U¡A |
|
|
·|û¡GPROTSAI10146704 µoªí®É¶¡:2018/10/25 ¤W¤È 11:24:03²Ä 4097 ½g¦^À³
|
¤¤¤¸¤@ÂI¬õ |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/25 ¤W¤È 10:36:55²Ä 4096 ½g¦^À³
|
¨â°¦¤j¶H¤@ª½½Ä¼²¡A¥[¤WÁp·Ç·|n¦¬¿ú¡A³Q¤t¤j¦hªÅÁ`¥q¥O¤@ª½¥s¡A¨ì©³½ÖĹ½Ö¿é... ²{¶¥¬q³\¦hӪѴX¥G³£¬ÝÄw½X±¡A¤×¨ä¬O¦³¿Ä¸êªº¡A¯u¬O¤j¨ü¨a¤á »sÃĥͧޤj³¡¤À¨S¦³¿Ä¸ê¡Aµy·L¦³³¡¤ÀÁ٧ܶ^ ¾ãÓ»¡¯uªº¶ÃÁVÁV ª÷¿Ä¥«³õ¯uªº¤£®e©ö°Ú¡A¤H©Êªº³Ì¨Î¸ÕÅç³õ |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2018/10/24 ¤U¤È 03:52:51²Ä 4095 ½g¦^À³
|
«¼C¥Sµoªí·s¤å³¹¤ÀªR¡G¡ugang806.blogspot.com/¡v ¨Ì·Ó±À½×¡ATrogarzo 9¤ëªº¤ë¾P°â¶q¡A¤w¶W¶VFuzeon 2014¦~ªº¥§¡¤ë¾P°â¶q¡C |
|
|
·|û¡G¶³²H·»´10146472 µoªí®É¶¡:2018/10/24 ¤U¤È 01:38:54²Ä 4094 ½g¦^À³
|
¨º¤@®aªk¤H¦ôªº, ³o»ò¤£±M·~, «¢. «æ¤F?? °OªÌ¤]¾ãӶöüg~~~ ²Ä¤T©u³£¨S´£¨ì ²Ä¥|©u¤S·U¦ô·U°ª, n¦A¨ÓÓ¤£²Å¹w´Á¶Ü... ²Ä¥|©u´Nºâ¦³0.35, ¥þ¦~¤]¤£¥i¯à¦³0.7§a. ¯à¥´¥´N¤£¿ù¤F. ¼Ú¬w¤W¥«n©ú¦~©³(¤½¥q¤½§i»¡ªº), þ¨Ó©ú¦~²Ä¤G©u¶}©l¾P°â@@ ¼ç¦b¥«³õ70~80 »õ¬ü¤¸, §ó§è, ¦h¤@Ó[¬ü]§a www.investor.com.tw/onlineNews/NewsContent.asp?articleNo=14201810240089 |
|
|
·|û¡G¶³²H·»´10146472 µoªí®É¶¡:2018/10/24 ¤U¤È 12:38:57²Ä 4093 ½g¦^À³
|
¦³¤Hª¾¹D³Ìªñªº¸³¨Æ·|¦ó®É¥l¶}¶Ü? |
|
|
·|û¡GJeff10147295 µoªí®É¶¡:2018/10/24 ¤W¤È 11:17:57²Ä 4092 ½g¦^À³
|
¦U¦ì¤j¤j¡A Ây¤j--ºZ¨¥¦³§Òª©--¶}ÄÀ¡I ¤p§ÌÄ´³ë¦p¤U¡G ====== ¡]¸Î¡^¤õ¤E«¤Ñ¡A°Às¤Q¤K´x¤wªñ¥G½m´N¡AÁö»¡¬O¯«¥\Ãø½m¡A»Ý¼z®Ú¡B®Ú°©¥[«á¤ÑW¾Ç¤è¨¬¥H¤p¦¨¡]¤£¦P©ó*¤Þ¤M¦Û®c*·Òªk¡^ Ây¤j¦³¤ß¤£Ã㨯W¡A½Î½Î´£ÂI¶}ÄÀ¡A¹ê¬O´ÀºZ¨¥ª©¥X¤O¤£¤Ö¡I ¡×==¡×= ¤µ¤é²¤¦³¡ãªì¸Õ®±¸}¡ã¨ý¹D¡I |
|
|
·|û¡GJeff10147295 µoªí®É¶¡:2018/10/24 ¤W¤È 10:39:38²Ä 4091 ½g¦^À³
|
¥ÍÂA¤j- ¯u¬O¦³¤ß¤H¡A´£¥XPence ¥ý¥Í¥H¬ü¤è¥ß³õªº凖*Àʤå*¦¡ªí¹F¡A¬J¾_¾Ù°ê»Ú¤]½ÄÀ»¤¤¦@¬FÅv¡]P¤óµø *¦@²£¬FÅv*»P*¤¤°ê¦Ê©m*¬°¨â½X¤l¨Æ¡^¡A¶T©ö¾Ô®£¥u¬O¤Á¤J¨¤«×¦Ó¤w¡A²`¼~*»¯©s¯à¶Q¤§¡A¥ç¥i¯à½â¤§*¥vų¡A³º¨£½Ñ¤µ¤é¡C ¦p¦óÁͦNÁפ¿¡H¤j«v°Ý¤]¡I |
|
|
·|û¡GÀH½t¦Û¦b10147011 µoªí®É¶¡:2018/10/23 ¤U¤È 12:47:45²Ä 4090 ½g¦^À³
|
¶³¤j¡A·PÁ´£¨Ñ¤À¨É HTI©MTLR7¬Ò©|¥¼¶i¤J¤HÅé¸ÕÅç¡A¶ZÂ÷¹F°Ó·~¹BÀç¥Ø¼Ð¡AÁÙ»»»»µL´Á¡I¤£»Ýn¤Ó¦h¾á¤ß¡I ¥H¤U¸`¿ýÀô²y¥Í§Þ¤ë¥Z ¶È¨Ñ°Ñ¦Ò AELIX Therapeutics S.L.¬O¤@®a±Mª`©ó¤@µoHIVªvÀøªº¤½¥q¡A¨ä«Å¥¬»PGilead¦X§@¡A±N¦@¦P¶i¦æÁ{§É¸ÕÅç¥H¬ã¨sAELIXªºHTI¬Ì]»PGileadªºTLR7³J¥Õ¡]Toll-like receptor 7¡^¬¡¤Æ¾¯vesatolimod¡]GS-9620¡^¡A¨ä¥\®Ä©Ê»P¦w¥þ©Ê¡A´Á±æ¯à¬°HIV±wªÌ³Ð³y§ó¦hªº§Æ±æ¡C HIV¡]Human Immunodeficiency Virus¡^§Y¬O¤HÃþ§K¬Ì¯Ê¥F¯f¬r¡A«UºÙ·R´þ¯f¬r¡C¥Ø«e¥i¤À¬°¨â«¬¡AHIV-1©MHIV-2¡CHIV-1¬O¤j¦h¼Æ°ê®a¤¤³Ì¥Dn³y¦¨·R´þ¯fªº¯f¦]¡CHIV-2¥Dn¤À¥¬¦b¦è«D¡C¨âºØ¯f¬rªºP¯f¤O¨Ã¤£¬Û¦P¡A·P¬VHIV-1«á¶W¹L90%ªº±wªÌ·|¦b10-12¦~¤ºµo¯f¦¨¬°·R´þ¯f¡C·P¬VHIV-2«h©¹©¹¨S¦³¬ÛÃöªº¯f¯g¡C ¦¹¦¸¦X§@±N¦@¦P¶i¦æ¦W¬°AELIX-003ªºÁ{§É¬ã¨s¡A¹wp¦b2019¦~ªì±Ò°Ê¡A¬°¤@¶µÂùª¼¡B¦w¼¢¾¯¹ï·Ó¤§¬ã¨s¡A¨ü¸ÕªÌ¬ù90¤H¡A¥ý±µ¨ü§Ü·R´þ¯f¬rªvÀø¡]antiretroviral therapy, ART¡^¤]´N¬O«UºÙªºÂû§À°sÀøªk¡A±NHIV¯f¬r±±¨î¦b¤@©w½d³ò¤º«á¡A¦A¥HHTI¬Ì]©Îvesatolimod¶i¦æªvÀø¡AÆ[¹î¨ä¦³®Ä©Ê»P¦w¥þ©Ê¡C HTI¬Ì]昰¥ÑAELIX Therapeutics¶}µo¡A¨ä³]p¬O¥Ñ©óT²ÓM¹ï©óHIV¯f¬rªº¬Y¨Ç°Ï°ì¯S§O¦³¤ÏÀ³¡AHTI¬Ì]°Ñ¦Ò¤F¤T¤j¬w¥|Ó¤£¦P±Ú¸s¡A±Nªñ1000¦W¯f±wªº§K¬Ì¼Æ¾Ú«á¡A«K±N³o¨Ç°Ï°ì³]p¦b¨ä¤¤¡A¿E¬¡T²ÓM¡A¨Ã¤w¸g¹L¦´Á¬Ì]¸ÕÅç¡A¦b¤p¹«»PônµU¸ÕÅ礤¬Ò±o¨ìÅçÃÒ¡C GS-9620¡]vesatolimod¡^¬°Gilead¶}µo¤§¤@ºØ¤fªAÃĪ«¡A¯à°÷¿E¬¡TLR7³J¥Õ¡A¶i¦Ó¿E¬¡§K¬Ì¨t²Î¡A¥]¬ACD4+ T²ÓM¡BCD8+ T²ÓM¥H¤ÎNK²ÓM¡A«á¨âºØt³dÂy±þ¨ÃºR·´¨ü¯f¬r·P¬Vªº²ÓM¡C Gilead Sciencesªº¬ãµoªøJohn McHutchisonªí¥Ü¡A¦¹¶µ¦X§@±N¶×¶°¨âºØ³Ì¦³«e´ºªºHIVÃĪ«¡A¥i¬°·R´þ¯f±w´£¨Ñ³Ì·sÀøªk¡AGilead¤Q¤À´Á«Ý»PAELIX Therapeutics¦X§@³o¶µÁ{§É¬ã¨s¤u§@¡C |
|
|
·|û¡G¥Í§Þ·sÂA¤H10146669 µoªí®É¶¡:2018/10/23 ¤U¤È 12:38:30²Ä 4089 ½g¦^À³
|
ºt»¡¥X³Bwww.whitehouse.gov/briefings-statements/remarks-vice-president-pence-administrations-policy-toward-china/ ½Ķ¹ï·Ó www.ait.org.tw/remarks-by-vice-president-pence-on-the-administrations-policy-toward-china/ ¦U¦ì¤¤¸Î§ë¸ê¤H¡A ¤j®a¦n! ¬Û«Hªñ´Á«Ü¦h¤H³£¦³¬Ý¨ì³o½gºt»¡. ½Ð¤j®a¦³ªÅ®É¡A°È¥²¬Ý¤@¤U¬ü°ê°ÆÁ`²Îªñ´Á°w¹ï¤¤°ê©Òµoªíªº³o¤@½gºt»¡¡C ¥Ñ©óª©¤W¤w¸g¦³³\¦hªº²{¦¨Â½Ä¶¡A¤j®a¥i¥H§Q¥ÎAIT ¬ü°ê¦b»O¨ó·|ªºª©¥»¡]§Ú¨Ã¨S¦³¬d¾\¡A¦ýAITªºÂ½Ä¶À³¸Ó¬Oȱo°Ñ¦Òªº¡^¤F¸Ñ¬ü°ê¹ï©ó¤¤¤è©Ò±Ä¨úªººA«×¡AÂÇ¥HÁͦNÁפ¿¡C |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/23 ¤U¤È 12:23:07²Ä 4088 ½g¦^À³
|
¨ä¹ê»sÃĥͧޤw¸gºâ¬O¬Û¹ï³Ì¤£®e©ö¨ü¨ì¶T©ö¾Ô¼vÅTªº±Ú¸s¡A°£¤F¤@¨Ç¦sªÑ«¬ªÑ²¼¨Ó¤ñ¤§¥~ ¦ý²{¦bªº°ÝÃD¬O°ê»Ú±¡¶Õ¤£©ú¡A¸êª÷¾ãÓ¬y¥¢¡A¨S¦³«H¤ß ©Ò¥H¨S¤°»òªÑ²¼®e©öº¦¡A°ò¥»¤W¯à¥ý¥´©³¡A¤£¯}©³¡A´N¬O¸U©¯¡A³£¤w¸g¬O«Ü¦n¤F ¬Ý¬Ý³Q°Ê±Ú¸s¡A¶^¨ì¨S¯R¨S®Q¡A³Ì¬O®£©Æ¡A¸ò¦~¤¤ªº°ª®p¡A¤j®a¦@Á¸²±Á|¡A¯u¬O¤Ñ°ó»P¦aº»ªº®t§O¡A¥xªÑ¯uªº¬Û·íÅå¤H ¦@«j¤§... |
|
|
·|û¡G¶³²H·»´10146472 µoªí®É¶¡:2018/10/23 ¤U¤È 12:04:04²Ä 4087 ½g¦^À³
|
FYI. AELIX»PGileadÄâ¤â¬°·R´þ¯f±w¶}©Ý·sÀøªk www.gbimonthly.com/2018/10/34152/?fbclid=IwAR3eIqrd7NPXpBOmYY8mzkjt-LLo0BD4YB1RjHconJv4Or6Oqm7UplnV2Qw |
|
|
·|û¡G¦µ¶©°^10147391 µoªí®É¶¡:2018/10/23 ¤W¤È 11:36:42²Ä 4086 ½g¦^À³
|
¤jÀô¹Ò¤£¨Î¡A¤j¨û¸ò¤j¶ýªº¶T©ö¾Ô«ùÄò¶i¦æ¡C ²{ªÑºM°h¡AÂà¶iµ¥¶qÅvÃÒ¡C ²{ª÷¬°¤ý§r¡C |
|
|
·|û¡Gmengs10146592 µoªí®É¶¡:2018/10/20 ¤W¤È 02:27:59²Ä 4085 ½g¦^À³
|
¥Ø«e¬Û¸û©óOTC¨ä¥LӪѡA4147¤w¸g¶}©l¥ý¶i¥h½L¾ã¤F¡AµuªÅÁͶդw¸g¨«§¹¡A¦ýªøªÅÁͶÕÁÙ¨S¡A³oÃä´£¿ô¤@¤U¡C ¦pªG§Aªº¸êª÷¬O¥i¥H¶RÓ´X¤Q±iªº¡A¦b¥Ø«e§¡½u¨«¥ªº®É¶¡ÂI¡A½T¹ê¤w¸g¥i¥H¶}©l¦Ò¼{¶i³õ¸Õ³æ µ¥¨ìªÑ»ù¤W¤F§¡½u¡A©Î¬Æ¦Ü±Ò°Ê¦hÀY¦æ±¡®É¤~¶}©l³°Äò¥[½X¡A³o¼Ë¬O³Ì¬°«OÀIªº¾Þ§@¤è¦¡¡C ©Ò¿×µuªÅÁͶը«§¹´N¬O»¡ªÅ¤F¨S¤°»ò¦×¡AÁÙ¦³°ª¾÷·|³QÂù¤Ú¡A¤£¹L4147¤£¯àªÅ¡C ¦ÓªøªÅÁͶժº·N«ä¬O¡A¥H©u¤ë½u¨Ó»¡ÁÙ¬O¤UÅs¥B¦©©è¬°t¡A³o¥Nªíªº·N«ä¬O¡A¦h¼Æ¤Hªº¦¨¥»³£°ª©ó²{»ù¡A¤]´N¬O»¡¡A°£¤Fª©¤W«Ü¦³«H¤ßªº©êªÑªÌ¥~(²¦³º¬O¤Ö¼Æ)¡A³\¦h¥i¯à©Ô°_¨Ó¥L´N·|·Q½æ±¼¡A§Î¦¨¸Ñ®M½æÀ£¡C ³o¤]¬O¬°¤°»òºÉ¶q¤£n¶R¦bªÅÀY±Æ¦Cªº¥Dnì¦]¡C§Þ³N«ü¼Ðªº¥»·N´N¬OÅý§A§äÓ¦nªº¶i³õ¥X³õÂI¡A³Ì²×ÁÙ¬O¦^Âk°ò¥»±¡A¨S¦³°ò¥»±ªºªÑ²¼´N¬Oª`©w«Ü§Ö½ö¥¡C ¤ñ¤è»¡Ù®·ªºIC³]p..º¦°_¨Ó§Ú´Nª½±µªÅ¤U¥h¡C ©Ò¥H¹³Rosetta¤j³o¼Ëªº¶Rªk¡A¨ä¹êÁÙ¦æ¡A¦]¬°²{¦b¶}©l¨«¥¡AÁöµMÁÙ¥i¯à¤U±þ¡A¦ýªø½u§ë¸êªÌ½T¹ê¥i¥H¶i³õ¡A§A¥unª`·N¤£n¶R¦b¤U°ÁͶմN¦n¡A¤]´N¬O8/3-9/12³o¬q®É¶¡¡A³oºØ§A¶i¥h¶R³Q®M¦ºªº¾÷·|«Ü°ª¡A¤d¸U¤£n¦³¡A§Ú¬Ýªø¡A§Ú¶R¨S®tªº¤ßºA¡A§Y«K¬O©w¦sªÑ¡A§A¤]¥i¯àŤFªÑ§Q¿é¤F»ù®t¡A¦Ó³oÓ»ù®t¥i¯àn¦n´X¦n´X¦~ªºªÑ§Q¤~¸É±o»ô¡C ²L¨£¤À¨É¡A¯¬¾Þ§@¶¶§Q |
|
|
·|û¡Gvito10147056 µoªí®É¶¡:2018/10/19 ¤U¤È 05:10:06²Ä 4084 ½g¦^À³
|
©¹¦n³B·Q 4147¦n¤ï¤]½L¾ã¤@Ó¦h¤ë¤F ¤ñ¨ä¥¦ªÑ¸û¦¸¨©³°Ú |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/19 ¤U¤È 04:48:53²Ä 4083 ½g¦^À³
|
¶³¤j¡A¬O¡A»sÃĥͧޡA¬Y¨Ç°£¤Fµu½u³Q§ë¾÷¸êª÷ª£°_¨Ó¤§«á¡A¯uªº³£¬Onµ¥¡A°ª·ÀI³ø¹Sªº¥Nªí ©Ò¥H§Ú¤§«e¤~¤@ª½»¡¥L̦b¥xªÑ±¾µP¡A¨ä¹ê¨Ã¤£»´ÃP¡A§ë¸ê¤H¤£»´ÃP¡A¤½¥q¤]¬O¡A¦]¬°±`±`ªÑ»ù·|·¥«×¨ü¨ì¥«³õª^³ò¼vÅT ¦ý·Q·Q¥xªÑ¹q¤lªÑ¡A¤]¦ó¹Á¤£¬O¡A±`±`¤@Ó¨å½dÂಾ¡A´N¥i¥H±q¤Ñ°ó¨ì¦aº»¡A¦Ó¥B¨ì¦aº»¤§«e¡A³£ÁÙ¬O¤@ª½¦³§Q¦h¥X²{ §ÚÁÙ¬O±o¦A´£¤@¦¸³Q°Ê©Î¬O¤§«eªº«õÄq·§©À »sÃÄÃþªº¡AÁÙ¬O¤]n¬Ýªø¡A¦ý¬Ýªøªº¹Lµ{¤¤¡A¬Ý¨Ó§Þ³N±¬O¥xªÑ¤ñ«n©ñ§ó°ªªº³¡¤À¡A¦]¬°¤@¯ë´²¤á¯à±q¤@¯ë³ø¸ü®ø®§±o¨ìªºªF¦è¡Aµu½u¤W³£¤ÓºC¤F 4147 ªºÉ¨÷§Ú»{¬°¡A´N¬O¤¤ªø´Áªº¬Ýªk¡þÄw½X¡þ·~ÁZªí²{ªº¦hªÅ¹ï¨M... Rosetta ¤j¡A §Úªº«Øij¬O¡A°²¦p§A¤£¬O«Ü³g¤ß¤pnºN©³ªº¤H¡A¨ä¹êµ¥¥¦ªÑ»ùÃ︤W¤ë½u¤§«á¡A·|¤ñ¸û«OÀI¤@ÂI ¦ý¥H¥xªÑ¤§«e³oºØ¶^ªk¡A¥´©³¹Lµ{¥i¯àn¦n¤@°}¤l¡A©Ò¥H¦³¨Ç³¡¦ì¡A³Ì¦nn«ù¬Õ«O®õ... |
|
|
·|û¡G¶³²H·»´10146472 µoªí®É¶¡:2018/10/19 ¤U¤È 04:36:02²Ä 4082 ½g¦^À³
|
ɨé½æ¥X³o»ò¦h, ¤]±Nªñ4%¤F ¦ý¤]¶^¤£¤U¥h, ¦bª±þ¤@©Û©O? Ãø¹D¥u¬OÁ×ÀI, Âê¦íÀò§Q. ÁÙ¬On¦A©Ô¤@¨Ç´²¤á·í¹ÔI... ¥t¥~TMB-355 IV PUSH ¨ì²{¦b³£ÁÙ¨S¤½§i¶}©l, ºâ¬ODELAY¤F§a. ºâºân¦¬®×¤H¼Æ+12¶gªºÀøµ{, ¦Ü¤Ö¤]n¥b¦~¥H¤W, ¥i¯à¤Sn¨ì©ú¦~Q3, Q4¤F. ·sÃįu¬O¿i@©Ê°Ú~~~DELAY ¯u¬O±`ºA. ¬Q¤Ñ¬Ý¨ì¥t¤@®aªº§K³dÁn©ú, ÁÙÆZ¦³½ìªº. §K³dÁn©ú ¤@¡B¥»Â²³ø«Y¥»¤½¥q¾Ú²³ø·í®É¤§¥D¡B«ÈÆ[¦]¯À¡A¹ï¹L¥h¡B²{¦b¤Î¥¼¨Ó¤§Àç¹B·JÁ`»Pµû¦ô¡C¨ä¤¤§t¦³«e¤©Ê¤§½×z¡A±N¨ü·ÀI¡B¤£½T©w©Ê¤Î±À½×©Ò¼vÅT¡A³¡¤À±N¶W¥X¥»¤½¥q±±¨î¤§¥~¡A¹ê»Úµ²½×©Î»P¦¹«e¤©Ê½×z¤£¦P¡C ¤G¡B¥»Â²³ø©Ò´£¨Ñ¤§¸ê°T(¥]§t¹ï¥¼¨Óªº¬Ýªk)¡A¨Ã¥¼©ú¥Ü©Î·t¥Ü¦aªí¹F©Î«OÃÒ¨ä¨ã¦³¥¿½T©Ê¡B§¹¾ã©Ê¤Î¥i¾a©Ê¡F¥ç¤£¥Nªí¥»¤½¥q¡B²£·~ª¬ªp¤Î«áÄò«¤jµo®i¤§§¹¾ã½×z¡C ¤T¡B¥»Â²³ø¤¤¹ï¥¼¨Óªº®i±æ¡A¤ÏÀ³¤½¥qºI¦Ü¥Ø«e¬°¤î¤§¬Ýªk¡AY¦³¥ô¦óÅܧó©Î½Õ¾ã¡A¥»¤½¥q¤£t§Y®É´£¿ô¤Î§ó·s¤§¸q°È¡C |
|
|
·|û¡GRosetta10146840 µoªí®É¶¡:2018/10/19 ¤U¤È 03:14:05²Ä 4081 ½g¦^À³
|
§Úªº·Qªk¦b§½¶Õ¥¼©ú±¡ªp¤U¡AÁקK«À£¥H¤Î¨S¸ò¨ì¤Wº¦¦æ±¡ ¤p§Ì²{¦bªºµ¦²¤¡A¨C¤ëµoÁ~¤é(³Ò°h¦Û´£6%+¤@¨Ç¹s¥Î¿ú)©T©w¶R4147¹sªÑ~³o¼Ë¤l¾Þ§@¡A¤£ª¾¹D¦U¦ì¥ý¶i¦³¦ó¬Ýªk¡ã ¬O§_¦³§óºë¶iªº°µªk¡A¹ï©ó§Ṳ́f³U¤£²`ªº¤pªB¤Í |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/19 ¤W¤È 11:51:21²Ä 4080 ½g¦^À³
|
¨ä¹ê°²¦p¥J²Ó¬Ý¡A¥i¥Hµoı 4147 ¸ò TH ¤ñ°_¨Ó¨ä¹ê¬O»â¥ý«ü¼Ð¡ATH ²{¶¥¬q¦ü¥G¦b¸ò¶^¤§«e 4147 ªº¶^´T ¦Ó¥B 4147 ½L¤¤´X¥G¤]³£¬O¸òµÛ¤j½L¦bÂ\°Ê ·íµM§Ú¤£´±»¡²{¦b¯uªº¬O©³¥X²{¤F¡A ²¦³º°ê»Ú±¡¶Õ¡AÁÙ¬O·|¼@¯P¼vÅT½L±¡A¬üªÑ¦b°ªÀÉ¡A¯uªº¥xªÑ¤w¸gÀ~¨ì½¡A¦³ÄY«®£°ª¯g ¥t¥~·f¤W¥´¦º¤£°hªºÉ¨÷¡AÁÙ¦³½L¤¤·í¨Rªº³æ¡A¤]¬O¤@Ó¼vÅT¦]¯À¡A¥u¯à¤j®aÀR¤ßÄ~ÄòÆ[¹î |
|
|
·|û¡GÀH½t¦Û¦b10147011 µoªí®É¶¡:2018/10/19 ¤W¤È 10:22:19²Ä 4079 ½g¦^À³
|
¥Í¤£³{®É¡I ´N¦b¨ú±oÃĵý¡A¸g¹L¥b¦~ªº«OÀIµ¹¥Iñ¬ù¡A º¯³z²v§Y±N©¹¥Ø¼ÐÁÚ¶iªº®ÉÔ¡A ³{8ªºª÷¿Ä·¼É(1998¡B2008¡B2018)³±¼v¡A¥u¦³@¤ßµ¥ÔÅo¡I |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/18 ¤U¤È 11:24:39²Ä 4078 ½g¦^À³
|
TH ¤µ¤ÑÄò¶^¨ì±µªñ 4147 ªº¬Û¹ï¦ì¸m §Ú²q¥[®³¤jªº¤¤¤pªÑ¡A¤]¬O¦h¤Ö¤]¨ü¨ìÃþ¦ü¥xªÑÂd¶R¥«³õ¤@¼Ëªº§C°gµ{«× ¤]°µ¤FÃþ¦üªº×¥¿... |
|
|
·|û¡GOOXX10022393 µoªí®É¶¡:2018/10/18 ¤W¤È 11:43:42²Ä 4077 ½g¦^À³
|
¾Ú¥ý«e³ø¸ü¡A±i©À컡¡A¤¤¸Î·sÃıµ¨ü¤ñº¸»\¯÷°òª÷·|¸êª÷ÃÙ§U¡A§ë¤J¹w¨¾·R´þ¯f·sÃIJĤ@´ÁÁ{§É¹êÅç¡A±ø¥ó¬O¥¼¨Ó¶·¥H¦¨¥»¥X°âÃÄ«~µ¹°òª÷·|¡A¦A¥Ñ°òª÷·|´©§U«D¬wªº·R´þ¯f°ª¦MÀI¸s¡C ½Ð°Ý¦ó®É·|¶}©l¥X³fµ¹¤ñº¸»\¯÷°òª÷·|¡H www.epochtimes.com/b5/9/12/11/n2751492.htm |
|
|
·|û¡Gctshu10147101 µoªí®É¶¡:2018/10/18 ¤W¤È 11:24:00²Ä 4076 ½g¦^À³
|
½Ð°Ý¦U¦ì¤j¤j:¤¤¸Î¥xÆWªº¥Í²£¤u¼t¡A°O±oì¹w©w¤µ¦~ªº9¤ë¥i§¹¦¨¡A¤£ª¾¶i«×¦p¦ó?¤½§G¶}©l¸Õ¨®®É¡AÀ³¬O§Q¦h®ø®§¡C |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/18 ¤W¤È 08:54:59²Ä 4075 ½g¦^À³
|
¨ä¹ê¥xªÑ¯uªº«Ü¦³½ì¡A§Ú¤£´±Â_¨¥ 4147 ±µ¤U¨Óµu½u·|¦p¦ó¨« ¦ý TH ¤§«eº¦¡A§Ṳ́]¤£¸ò¡A¤Ï¦Ó¥ý»â¶^¡A²{¦b¥¦¸ò¶^¡A§ÚÌ¥xªÑ´Nn¦A¸ò¶^ ªº½Tȱo¤j®a¦n¦nÆ[¹î¡A¨ì©³¬O¤£¬O¥xªÑ¦H®Ú©Ê¤Ó«...XD |
|
|
·|û¡G¥±`¤ß10136733 µoªí®É¶¡:2018/10/18 ¤W¤È 08:35:49²Ä 4074 ½g¦^À³
|
TH³sÄò¨â¤Ñ¤j¶^ ¬Ý¨ÓªÅŧĵ³øÁÙ¨Sµ²§ô |
|
|
·|û¡G¦n¹B10137114 µoªí®É¶¡:2018/10/17 ¤U¤È 05:04:47²Ä 4073 ½g¦^À³
|
¹ï©ó¼Ú¬w©t¨àÃĪº³¡¤À´£¥X¨âÂI¬Ýªk 1. ©t¨àÃĪº¦n³B¦b©ó¥[§ÖÃÄÃÒ¼f®Ö¡A³oÂI±i¸³¦b2017¦~¼Ú¬w±ÂÅvªº»¡©ú·|¦³´£¨ì¡C Áö¼Ú¬w¬Û¸û¬ü°ê¨S¦³©t¨àÃÄ¡A¦ý¦³¬ü°êÁ{§É¤T´Áªº¼Æ¾Ú¡C¦]¦¹»{¬°¼f®Ö®É¶¡¤£·|¼vÅT¤Ó¦h¡C ²{¦b®Ú¾Ú¼Ú¬w°e¥óªº¶i«×¡AÃÒ©ú³o»¡ªk¬O¨S¿ùªº¡C 2. »¡©ú·|±i¸³¤]´£¨ì¡A¼Ú¬wÀò§Qªº³¡¤À¹wp¬O¬ü°ê¥«³õªº50¡ã70%¡C³o¤]¬O¦b¨S¦³©t¨àÃĸê®æ®Éªº¹w¦ô¡C |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/17 ¤U¤È 04:28:06²Ä 4072 ½g¦^À³
|
°£¤FÆ[¹îº¯³z²v¡A¥xªÑ¥t¤@Ón¯À¡A ´N¬O¥xªÑ¤¤³Q¶T©ö¾Ô¨â°¦¤j¶HÀ~wªº¤º¸ê¤Îªk¤H¡]ªk¤H¤]«Ü¦h¬O°òª÷¡A¤]·|³QÅ«¦^¡^ ³o¬O¥xªÑªºì¸o¡A¨â°¦¤j¶H¤¬½ò¡A¥xªÑÁ`¬O¨S¦³¦nÁy¦â¡A´X¥G¤j³¡¤ÀªºÓªÑ³£³o¼Ë¡A ©Ò¥H³£¬O«Ü®e©ö¾ãÓ½L¶Õ³£¬O«D±`µu¶iµu¥Xªº¸êª÷¡A¦b§Ö³t¬y°Ê ¬Ý¦h¬ÝªÅ¡A³£ÁÙ¬OnÄ~Äò«ù¬Õ«O®õ.... |
|
|
·|û¡GÀH½t¦Û¦b10147011 µoªí®É¶¡:2018/10/17 ¤W¤È 11:08:13²Ä 4071 ½g¦^À³
|
Russell ¤j ²{¶¥¬qÃöª`ªºµJÂI¬O¥_¬üªºº¯³z²v¡I ¥unº¯³z²v²Å¦X¹w´Á(©ú¦~¥|¤ë¥X³f¹F¤@¸U²~)¡A ¨ä¾lªº¼vÅT©Ê³£¤£¤j¡I ¤p§Ìªº²L¨£¡AÁٽЫü¥¿¡I |
|
|
·|û¡GPROTSAI10146704 µoªí®É¶¡:2018/10/17 ¤W¤È 10:53:38²Ä 4070 ½g¦^À³
|
©t¨àÃįà«OÅ@¬Æ»ò ? ±M½æ´Á? °Ý°Ý¤½¥q´Nª¾¹D ³o°}¤l¶^ÁÙ¤£ª¾¹Dì¦]? ¶Â£~£°¶Â ÁÈ¿ú¤£½æ·í¶Ì¤l°Ú |
|
|
·|û¡GRussell10140734 µoªí®É¶¡:2018/10/17 ¤W¤È 08:58:25²Ä 4069 ½g¦^À³
|
²ö«D¡K ¨S¦³©t¨àÃÄ«OÅ@¡A¬O³o°}¤l¤U¶^ªºÁôÂæ]¯À¡H¡H ¦³¤j¤j¥i¥H¤ÀªR¶Ü¡H |
|
|
·|û¡GStockHolder10147298 µoªí®É¶¡:2018/10/17 ¤W¤È 02:57:22²Ä 4068 ½g¦^À³
|
³Q¦C¦bNon-orphan medicinal product? Ibalizumab¦b¼Ú¬w«DÄÝ©t¨àÃĽdÃ¥¡A¬O§_·N¨ýµÛÃÄ»ù¨üºÞ¨î¡A¦ý¾A¥Î¯f±w¼ÆÂX¤j¡H©¹«e½u©µ¦ù¶Ü¡HÁÙ¬O¼Ú¬wMDR¤H¼Æ²³¦h¡A¤£²Å¦X©t¨àÃÄ©w¸q¡H |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/16 ¤U¤È 11:36:31²Ä 4067 ½g¦^À³
|
«Ü²³æ°Ú¡A¤j·§´N¬O¦hªÅ¹ï¨M¡A³o¤ä¤j®a³£¦b¬Ý«áÄòº¯³z²v±¡§Î¡A¦³¤HÄ@·N¬Û«H¡A¦³¤H¤£¬Ý¦n¡A©Î¦³XX ¸ê¦³¦h³æ¡A¥¦¥t¥~·QÁ×ÀI¡A«Ü¦h¥i¯à «áÄò¦ÛµM´N·|¥X¤@Ó¤è¦V.... |
|
|
·|û¡GÄ_Ä_10138124 µoªí®É¶¡:2018/10/16 ¤U¤È 09:43:49²Ä 4066 ½g¦^À³
|
½Ð°Ý¦U¦ì°ª¤â¡ã¤¤¸Îɨ÷½æ¥X¨C¤Ñ³£¼W¥[¡I§Ö¯}¸U±i¤F¡I¥Î·N¦p¦ó¡H |
|
|
·|û¡G¶³²H·»´10146472 µoªí®É¶¡:2018/10/16 ¤U¤È 03:18:32²Ä 4065 ½g¦^À³
|
FYI. ¥i¥H¬Ý¨ìIbalizumab ¤w·s¼W. ¥[³t¼f¬d¸ê®æ: 5/71. Applications for new human medicines under evaluation by the Committee for Medicinal Products for Human Use www.ema.europa.eu/documents/report/applications-new-human-medicines-under-evaluation-committee-medicinal-products-human-use-october_en.pdf |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/16 ¤W¤È 10:30:37²Ä 4064 ½g¦^À³
|
finance.yahoo.com/news/theratechnologies-appoints-board-member-113000757.html?.tsrc=rss Theratechnologies Appoints New Board Member ¥i¯à¼vÅT¤£¤j¡A°Ñ¦Ò¬Ý¬Ý |
|
|
·|û¡GJeff10147295 µoªí®É¶¡:2018/10/12 ¤U¤È 05:34:29²Ä 4063 ½g¦^À³
|
¦µ¤j¡A Smart guy this time to buy, maybe your coin call you in advance. |
|
|
·|û¡G¦µ¶©°^10147391 µoªí®É¶¡:2018/10/12 ¤U¤È 12:55:38²Ä 4062 ½g¦^À³
|
¶XµÛ±¼¤U¨Ó¡A¦¤W¶R¤@±i¡C ¥§¡¤@¤U¦¨¥»¡C |
|
|
·|û¡GÀH½t¦Û¦b10147011 µoªí®É¶¡:2018/10/12 ¤W¤È 10:51:11²Ä 4061 ½g¦^À³
|
¤£ºÞ§½¶Õ¦p¦ó°ÊÀú¡IMDRªº¯f¤H¤´µM»Ýn¨Ï¥ÎTrogarzo ¡I¤Á¤Å¦k¦ÛµáÁ¡¡I ¬O§_¦³(¥b¤d)¡H¤°»ò®ÉÔ(¥b¤d)¡H ´Nµ¥11¤ëªì¤½¥¬À禬¡I¤j®a³£¦b´Á«Ý¡I |
|
|
·|û¡G¶³²H·»´10146472 µoªí®É¶¡:2018/10/11 ¤U¤È 08:31:16²Ä 4060 ½g¦^À³
|
·PÁÂÂy¤jªº»¡©ú¡C |
|
|
·|û¡GÂyªÌ10142287 µoªí®É¶¡:2018/10/11 ¤U¤È 08:18:17²Ä 4059 ½g¦^À³
|
¶³¤j©Ò´£¤Îªº, ³Q«õ¨¤¤F¡H Stanley Lewis Âå¾Ç³Õ¤h Âå¾Ç°ÆÁ`µô ¬ü°ê¥ð¤h¹y¼w¦{Âå¾Ç°|Âå¾Ç³Õ¤h «e¬ü°êGenentech¤ÎTanox¤½¥qÂå°È¥DºÞ www.prnewswire.com/news-releases/ ansun-biopharma-announces-key-appointments -to-its-executive-management-team-300725045.html ⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯ ¥t¥~¦³ÃöLewis³Õ¤hÂ÷¥h¤@¨Æ¡A ¤µ¤ÑÂy ¤H©Òª¾¹Dªº¬O¡A¨Ã¤£·|¼vÅT«áÄòªº¦U¶µÁ{§É¸ÕÅç¡A ¦]¬°¬ü°ê¤¤¸Î¤l¤½¥q¡A¦¤w¸g¶¶§Q¥Ñ¦ó¤j¤@³Õ¤hªº¡u¦ãÛÀ¹º¸»X¹êÅç«Ç¡v¡A ¸u¥ô¤F¤@¦ì¸ê²`Á{§É¸ÕÅç±M®a¡A©Ò¥H⋯^_^¡I ¦^ÂÐ¥»¤å ¦^¤W¥«Âd°Q½×°Ï1¶ |
|
|
·|û¡GHBLin10142111 µoªí®É¶¡:2018/10/11 ¤U¤È 04:44:51²Ä 4058 ½g¦^À³
|
·s¥x¹ô¶S1.37¨¤¦¬31.105¤¸ 20Ó¤ë¨Ó·s§C ¥x¹ô¶SÈ¡A¬O§_¯à¦P®ÉѺª`¥H¬ü¤¸³c°âªºTrogarzoÀ禬¼Æ¦r¡H |
|
|
·|û¡G¦µ¶©°^10147391 µoªí®É¶¡:2018/10/11 ¤U¤È 03:59:24²Ä 4057 ½g¦^À³
|
³oºØ¶^ªk¡A¤£´Á«Ý¯à¸m¨¨Æ¥~¡C ¦n¥i©Èªº±þ½L¡C |
|
|
·|û¡G54310143745 µoªí®É¶¡:2018/10/11 ¤U¤È 12:35:13²Ä 4056 ½g¦^À³
|
§ë«H¤S¦í®M©Ð¤F¡I |
|
|
·|û¡G¶Wô10139528 µoªí®É¶¡:2018/10/11 ¤W¤È 11:53:03²Ä 4055 ½g¦^À³
|
ÂE®ü¥i¥H¶R¦b60´X¤¸¡AµM«á50´X½ß¿ú½æ±¼¡A¥u¯à»¡¹B®ð¯uªº¤£¦n¡C¾ú¥v§CÂI¤F¡I |
|
|
·|û¡GPROTSAI10146704 µoªí®É¶¡:2018/10/11 ¤W¤È 11:42:54²Ä 4054 ½g¦^À³
|
¸I¨ìªÑ¨a ©Ò¦³¬}(¯Ê¤f) ¸É¦n¸Éº¡ |
|
|
·|û¡GPROTSAI10146704 µoªí®É¶¡:2018/10/11 ¤W¤È 10:26:01²Ä 4053 ½g¦^À³
|
§Ú´¿¸g¤»¤Q´X¶RÂE®ü½ß¿ú ¤¤Q´X½æ±¼ ¼Ú¶Å·¼É®É. ¥Ø«en¦Ò¼{Á`Åé¸gÀÙ ¬y°Ê©Ê·ÀI ´º®ð¤U¦æ·ÀI ¥x®ü¾Ôª§ |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/11 ¤W¤È 10:22:17²Ä 4052 ½g¦^À³
|
¥¿©Ò¿×¸¨ªá®É¸`¤S³{§g ¦n¹³ª©¤W¦³É¨÷ªº¤H¤]°Û±o«Ü«æ ¦ó¤£¤j®a§NÀR¤U¨Ó¡A¦h¬Ý¬Ý¨ì©³·|¦p¦ó¨« |
|
|
·|û¡GRosetta10146840 µoªí®É¶¡:2018/10/11 ¤W¤È 10:12:28²Ä 4051 ½g¦^À³
|
9¦¨¤w½æ¥Xªº«ùªÑ©|¥¼Á٩жU¡AÆ[¹î¤@¤U¤¤¸Î¥i¨ì¦h§C⋯⋯§ìÓ¦X²zªº¦w¥þÃä»Ú¡A¦Ò¼{¶Rªù²¼¤J³õ¡C |
|
|
·|û¡GPROTSAI10146704 µoªí®É¶¡:2018/10/11 ¤W¤È 09:53:51²Ä 4050 ½g¦^À³
|
¬ðµo¨Æ¥ó , ¤@¦Ê¦~«á¦^¸É, ºâ¤£ºâ¦^¸É? §Þ³N¤ÀªR¥u¬O°Ñ¦Ò ¾a§Þ³N¤ÀªR¦Y¶º, ÁÙn¤@ªù¥\¤Ò -----¦Û¶ê¨ä»¡ |
|
|
·|û¡Gyu76021610146652 µoªí®É¶¡:2018/10/11 ¤W¤È 09:33:42²Ä 4049 ½g¦^À³
|
»¡¦nªº¯Ê¤f¦^¸É......Áà·@°ü¬O¸Ó¨£¤½±C¤F...ü |
|
|
·|û¡GPROTSAI10146704 µoªí®É¶¡:2018/10/11 ¤W¤È 09:28:55²Ä 4048 ½g¦^À³
|
¤K¤j¸ò°ê¦w ¥¼¤R¥ýª¾ |
|
|
·|û¡Gyu76021610146652 µoªí®É¶¡:2018/10/11 ¤W¤È 08:52:24²Ä 4047 ½g¦^À³
|
n°µª½¹F¨®¹Æ...±¡Ã´¦n¦w¥þ±a.....¥[ªo¹Æ |
|
|
·|û¡G¹A¤Ò10147224 µoªí®É¶¡:2018/10/10 ¤U¤È 06:11:42²Ä 4046 ½g¦^À³
|
³o¤GÓ°ÝÃD¥Ñ¹A¤Ò¨Ó¦^µª§Y¥i 1.Y´ä¹ô.¤H¥Á¹ô«±¤F¹ï¥xÆWªÑ¥«ªº¼vÅT«Ü¤j 2.¥xÆWªºªÑ¥«¦³¥i¯à¸òµÛ«± ¥un§â°Ý¸¹®³±¼´N¥i¦^µª¤F ¥u¬O°²³]©Êªº°ÝÃD ¹ê²{ªº¾÷²v¦³´X% ³oÓ¤ñ¸û«n Y¦³½×z ¤£§«»¡§ó²M·¡©ú¥Õ |
|
|
·|û¡G¤g¼·¹«10147669 µoªí®É¶¡:2018/10/10 ¤U¤È 02:06:12²Ä 4045 ½g¦^À³
|
½Ð°Ýª©¤W¤j¤j¨âÓ°²³]©Ê°ÝÃD 1:Y´ä¹ô.¤H¥Á¹ô«±¤F¹ï¥xÆWªÑ¥«ªº¼vÅT¬O¦n¬OÃa.¼vÅT¼h±¦h¤j???? 2:¥xÆWªºªÑ¥«¦³¥i¯à¸òµÛ«±¶Ü??? |
|
|
·|û¡G¶³²H·»´10146472 µoªí®É¶¡:2018/10/9 ¤U¤È 08:48:57²Ä 4044 ½g¦^À³
|
³Q«õ¨¤¤F¡H Stanley Lewis Âå¾Ç³Õ¤h Âå¾Ç°ÆÁ`µô ¬ü°ê¥ð¤h¹y¼w¦{Âå¾Ç°|Âå¾Ç³Õ¤h «e¬ü°êGenentech¤ÎTanox¤½¥qÂå°È¥DºÞ www.prnewswire.com/news-releases/ansun-biopharma-announces-key-appointments-to-its-executive-management-team-300725045.html |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/9 ¤U¤È 01:03:46²Ä 4043 ½g¦^À³
|
ªÑ¥«°]¯Tªê°\¤@°ï ³Q°Ê·í®É¤£¶R¤£¦æ¡A¹ï¤£°_¯ª©v¤K¥N 8436 «ë¤Ñ°ª¡A·~ÁZ¤ë¤ë°ª¡Aµ²ªG³o¥b¦~¶i¥Xªº¤]¥þ³¡®M¨c¦b¤s³»¡Anª¾¹D³Q¹L«×¹w´Á«á®M¨c¦b¤s³»¡A ¤£³B²z¡A¬O·|¦³«Ü¤jªº¶Ë®`¡A§Ú¦b¤§«e´N´£¹L8436 §Q¦h¤w¸g©ñ¨ì¨S³B©ñ 4147 ¸Ó³Q¥ý¹w´Áªº¤]¤w¸g¥ý´£«e³Q¤ÏÀ³¡A·íµM¤§«á´N¬On¬Ý«áÄò©³µP¡A ªÑ¥«8/2 ¬Æ¦Ü 9/1 ªk«h ¤£ºÞ¬Ý¦h¡þªÅ¡A³£¬O¤@¼Ë ÀR¤U¤ßÆ[¹î |
|
|
·|û¡GPROTSAI10146704 µoªí®É¶¡:2018/10/9 ¤W¤È 11:41:51²Ä 4042 ½g¦^À³
|
±K»y: MLB |
|
|
·|û¡Gmengs10146592 µoªí®É¶¡:2018/10/9 ¤W¤È 11:24:30²Ä 4041 ½g¦^À³
|
«ÜÃø¦uªº¡A¥un¤£n¦A«×¨«ªÅ´N±j¹L¤@¥b¥H¤WӪѤF¡C¨Æ¹ê¬O¡AÂd¶R«ü¼Æ¶^´T¤w¸g¶W¹L2015¤H¥Á¹ô¦M¾÷ªº¤pªÑ¨a¶^´T¤F¡A¦U¦ì«O«¡A¦^¯«À³¸Ó·|¦n¤@°}¤l¡C³o°}¤l´N¥h¶¢¶³³¥Åb§a¡AÀ³¸Ó¤@°}¤l¤£·|¦³¦æ±¡¡AÂб_¤§¤UµL§¹§Z |
|
|
·|û¡Gn¦³¦n¹B®ð10145611 µoªí®É¶¡:2018/10/9 ¤W¤È 11:20:12²Ä 4040 ½g¦^À³
|
¦u¤£¦í200¤F |
|
|
·|û¡Gyu76021610146652 µoªí®É¶¡:2018/10/9 ¤W¤È 11:18:22²Ä 4039 ½g¦^À³
|
§ë¸ê·sªk.......®M¨ì¤Ñ¯î¦a¦Ñ...¥[ªo¹Æ...´Á«Ý°²ÄÀªº¨º¤Ñ§ÚÌ180¥H¤U¨£ |
|
|
·|û¡G¶³²H·»´10146472 µoªí®É¶¡:2018/10/9 ¤W¤È 09:42:17²Ä 4038 ½g¦^À³
|
¼@¥»¤Sn¶}©lºt¤F??? ¶}°ª¨«§C¦¬³Ì§C~~~ ¬Q¤Ñ²Ä¤@¤Ñ!!! |
|
|
·|û¡Gmengs10146592 µoªí®É¶¡:2018/10/9 ¤W¤È 12:17:30²Ä 4037 ½g¦^À³
|
¯d¤¤¸ÎÆ[¹î¥¿½T¡A¥xªÑ²{¦b¥D¬y´N¬O¥Í§Þ¡C ¤j½L¶g½uªø¶Âáè¯}¦Ü¥¬ªLy¹D¤U½t¡A²{¦bªº½L´N¬O®z¨ìú¥X¨Ó¡C§ó§O»¡¤w¸gºL¨ì2015¤ô¥ªºÂd¶R«ü¼Æ¤S¯}§C¡A°ò¥»¤W¨â¦~¨Óªø§ëªºªB¤Í¡A¥un§A¦³¶R¨ìÅvȪѪº´X¥G³£¬O°µ¥Õ¤u¬Æ¦Ü½ß¿ú¡C ¥u¯àµ¥¤îæA»¡¤F¡C¤j®a¤@°_¥»¯q¤ñ×¥¿¡A¯uªº¦³¹ê¤Oªº®ÉÔ¨ì¨Ó®É·|®³°_²Ä¤@´Îªº¡I°ò¥»±´N¬O¦b½L®z/±Y½L®É¤~·|Åã²{¥X¯u¥¿ªº»ùÈ |
|
|
·|û¡GRosetta10146840 µoªí®É¶¡:2018/10/8 ¤U¤È 11:12:03²Ä 4036 ½g¦^À³
|
³o´X¤Ñ¤j½L¡AÅý§Ú·Pı¿éªº¾÷·|°ª...³s§Ú¦Û¤v¤µ¤Ñ´N½æ¤F9¦¨¥ª¥kªº«ùªÑ(¥u¯d¤¤¸Î)¡A¥ý®³¨ÓÁ٩жU... ²{¦b·Q±Ä¥Î¡A¶R¹sªÑªº¤è¦¡¨C¤ë¶R¶i...¤@Ó¤ë¶R1~2¸U¡A¨Ó´î»´³æ±i«©ãÀ£¤O¡A¤À´²·ÀI |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/8 ¤U¤È 09:28:19²Ä 4035 ½g¦^À³
|
Ä~ÄòÄw½X¤j¹ï¨M ¦UºØ¥¿¡þ¬n¸ê¡A«ùÄò³{°ª¤p¶qɨ÷Á×ÀIÅu¥¡H ·f¤W¥xªÑ¿n®z¤£®¶¡A¥«³õ¤W½Ö·|Ĺ©O¡H Ä~Äò¬Ý¤U¥h... |
|
|
·|û¡GPROTSAI10146704 µoªí®É¶¡:2018/10/8 ¤U¤È 02:20:50²Ä 4034 ½g¦^À³
|
¶i³õÂIº}«G µ½³]°±·l°±§Q §ë¥Í§ÞªÑ¥²³Æ§Þ¯à ¤£µM´N¬O·íº»¤Í¤F ³Ì¦n¸ò®]@ ¦s ÃQ³±¥æ ¬°¤Í ÁÙ¥i½m¥\ |
|
|
·|û¡GPROTSAI10146704 µoªí®É¶¡:2018/10/8 ¤U¤È 01:57:35²Ä 4033 ½g¦^À³
|
¹ï³½¼uµ^ µL¨¥¤F |
|
|
·|û¡Gyu76021610146652 µoªí®É¶¡:2018/10/8 ¤U¤È 12:45:55²Ä 4032 ½g¦^À³
|
Ãø©Ç¥u¯à·íº»¤Í....ÁÙ¦b¦k·Q¸Uºñ¤@ÂI¬õ...¥[ªo§a..¬Ý¬Ýþ®É¯à°²ÄÀ¤F |
|
|
·|û¡GJACKY WU10147205 µoªí®É¶¡:2018/10/8 ¤W¤È 10:56:44²Ä 4031 ½g¦^À³
|
¤d¸Un¤p¤ß4147¸q«i«æ¥ýx¶R¤F1500¦h·|¤£·|¤S³Q¬~¤@¦¸ |
|
|
·|û¡GPROTSAI10146704 µoªí®É¶¡:2018/10/8 ¤W¤È 08:51:34²Ä 4030 ½g¦^À³
|
¶Ì¥Ê§ë¸ê¤ßªk : ¦pªG¤j½L¦]¬°«¤j§QªÅ(¾H¤p¥¦º¤F ºô¸ôªwªj ¨È¬wª÷¿Ä·¼É ¼Ú¶Å·¼É ¨â¨¾·¼É ) º¡½L¬Òºñ ¸UºñÂO¤¤¤@ÂI¬õ ´N¬O¥D¤O¤j¤H¦bùØÀY «i´± ..... |
|
|
·|û¡GJeff10147295 µoªí®É¶¡:2018/10/7 ¤U¤È 11:21:06²Ä 4029 ½g¦^À³
|
¦n¹B¤j¡A ÅÞ¿è¤W¨Ó»¡¡A°ª®p´Á¥Ãªº¼Æ¾Ú¡A¬Û¹ïÀ³©ó ¤ë¥÷¦ü¥G¸û¦³·N¸q¨Ç¡I |
|
|
·|û¡G¹A¤Ò10147224 µoªí®É¶¡:2018/10/7 ¤U¤È 10:24:12²Ä 4028 ½g¦^À³
|
´I¶QÀI¤¤¨D¶Ü ³o¼Ë¾Þ§@ªº¤H «Ü¦h²{¦b¯ó³£ªø«Ü°ª¤F |
|
|
·|û¡G¹A¤Ò10147224 µoªí®É¶¡:2018/10/7 ¤U¤È 09:51:55²Ä 4027 ½g¦^À³
|
¦b¬Æ»òª¬ªp³Ì©ö»~½ò³´¨À©O ¤ß«æ ¤j³g n¦b¥«³õ²Ó¤ôªø¬y ´Nn§Ù°£³o¤G¶µ¤£§Q¤ß²zª¬ºA ¤~¤£·|¤j°_¤j¸¨ |
|
|
·|û¡G¹A¤Ò10147224 µoªí®É¶¡:2018/10/7 ¤U¤È 09:40:33²Ä 4026 ½g¦^À³
|
Ó¤Hµo¨¥µL¦hªÅ¥ß³õ ¥u¬O³¯z¶·¦³·ÀIÆ[©À YÃĹªº ¥b©]¤]n±Æ¶¤©é¿éĹ |
|
|
·|û¡G¹A¤Ò10147224 µoªí®É¶¡:2018/10/7 ¤U¤È 06:20:55²Ä 4025 ½g¦^À³
|
ªø´Á¦Ó¨¥(¦hªø©O)¡A§Y¨Ï¶R¦b349.5À³¤]¦³¾÷·|Àò§Q ¦ý²{¦b¤j®aÀ³³£¤£§Æ±æ¦Û¤v¬O¶R¦b349.5ªº¤H |
|
|
·|û¡G¹A¤Ò10147224 µoªí®É¶¡:2018/10/7 ¤U¤È 06:07:28²Ä 4024 ½g¦^À³
|
¥D¤O¤â°©«Ü²Ê ¦ý´N¤£ª¾°¦¤ânÀ³¥I¦h¤Ö¤è¦ì ÁÙ¦³¹ï¥´ªº¬O´XÓ¤H ¥H¤Î¬O§_Áٻݻ°³õ¤ä´©©O |
|
|
·|û¡G¹A¤Ò10147224 µoªí®É¶¡:2018/10/7 ¤U¤È 05:59:20²Ä 4023 ½g¦^À³
|
ÁÙ¦bµoµP¤¤ªº½ä§½ YµP±ÁÙ¤£¿ù ¥i©ã«¨Ç YµP±ÁٻݫᱵoµP¸É¤W¦nµP ´N¤£¥i±ô«¢ ¨Cµo¤@¦¸µP¡A½Õ¾ã¤ñ« À³¬O¸û°È¹ê½äªk ÁÙ¨Sµo§¹µP©Î¥¼¹F¨ìÃöÁäµP± ¤@¤Á³£¬O¥¼ª¾¼Æ |
|
|
·|û¡G¦n¹B10137114 µoªí®É¶¡:2018/10/7 ¤U¤È 03:55:56²Ä 4022 ½g¦^À³
|
¨ä¹ên¤F¸Ñ³oÓ°ÝÃD¤]¤£Ãø¡A¤½¥q¨Ì¾Ú´XºØ·R´þ¯fÃĦ¨¥\ªº¤W¥««á¾P°â¦±½u¡A ¤~¦³ªk»¡·|³ø§i¤¤¤W¥«¦~¼Ævsº¯³z²vªº¹Ïªí¡C ¥unÀH«K§ä´XÓ·R´þ¯fÃĪº¾P°â¡A¨ú¤W¥««á²Ä¥|Ó©u«×¸òpeak sales¬Û¤ñ¡A ¸ò¨ú²Ä¤@¦~¥§¡¾P°âªº¾P¶q¸òpeak sales¬Û¤ñ¡A¬Ý¬ÝþÓ¤ñȤñ¸û±µªñ25¡ã30%¡A´N¥i¥Hª¾¹Dµª®×¤F¡C |
|
|
·|û¡GÂyªÌ10142287 µoªí®É¶¡:2018/10/7 ¤U¤È 03:24:20²Ä 4021 ½g¦^À³
|
¥¦«üªº¬O¡A ©ú¦~4¤ë¥÷¥X³f¬O¾P°â°ª®p´Áªº20¡ã30¢H¡A ÁÙ¬O²Öp¨ì©ú¦~4¤ë©³ªº²Ä¤@¦~¾P°â¶q¡A ·|¬O¾P°â°ª®p¦~ªº20¡ã30¢H¡A ³oÓ®t«Ü¤jªº |
|
|
·|û¡GÂyªÌ10142287 µoªí®É¶¡:2018/10/7 ¤U¤È 03:18:07²Ä 4020 ½g¦^À³
|
Ây¤H¤]¤£ª¾¹D¤½¥q¦^Âе¹¤Í¤Hªº ³o¬q°T®§⋯, ----------------------------------------------- ±q¤C¤ë°_³v¤ë¤W¤ÉÁͶդ£Åܦܲĥ|¦~ ³oÓ¹w´Á¤£·|¦³ÅÜ ¤@ª½¨ì¶}½æªº²Ä¤@¦~©³¡]©ú¦~¥|¤ë©³¡^ ¨º®ÉÔÀ禬´N®t¤£¦h¬Opeak saleªº¬ù 20%-30%¥ª¥k TH¤]»{¬°²{¥¿¾P°â»Pì¹w´Ápeak sale ¤]¨S¦³»Ýn×¥¿ ©ú¦~Y¼Ú·ù¨úµý¤W¥«2020¦~«á¤S¦A¥[¤W ¼Ú¬w¾P°â ¤¤¸Î§Ú¦³«H¤ß ÁͶդ£ÅÜ ±q§Úªº iPhone ¶Ç°e ⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯ |
|
|
·|û¡GJeff10147295 µoªí®É¶¡:2018/10/7 ¤U¤È 03:04:42²Ä 4019 ½g¦^À³
|
Ây¤j¡A ¦pªG¦~©³¹F10%,¨º¤]²Å¦X¤½¥qì¨Óªº»¡ªk¡A¸gÀç¹Î¶¤¤Ó....¤Ó«n°Õ¡I ¥t¤è±¡A¦p¦~©³¤ëÀ禬ªñ1.1∼1.2E¡A¨º©ú¦~4¤ë©³À禬¡H °ª®p´Á¤ëÀ禬§ì5X,«h2021∼2022¤ëÀ禬»P¦~À禬´N»á¦³¨Ç¥iÆ[¹Æ¡I |
|
|
·|û¡GÂyªÌ10142287 µoªí®É¶¡:2018/10/7 ¤U¤È 12:19:23²Ä 4018 ½g¦^À³
|
¥t¥~¥Ø«eªº«OÀIÂвv²v¬ù69¢H¡A Th.¤½¥qªº¥Ø¼Ð¬O¥¼¨Ó´XÓ¤ë¡A±NÂл\²v¹F¨ì80¢H¡A image: www.stockhouse.com/CMSModules/Avatars/CMSPages/GetAvatar.aspx?maxsidesize=38&avatarguid=42f9d97e-b0c8-43a2-8a35-62dfec5ae64a User avatar FredTheVoice image: www.stockhouse.com/Stockhouse/images/stars-mask.png 2 stars User Actions October 06, 2018 - 09:02 AM 163 Reads Post# 28756974 Rate this post image: www.stockhouse.com/Stockhouse/images/stars-mask.png 0 starsv Article in LES AFFAIRES www.lesaffaires.com/bourse/analyses-de-titres/a-surveiller-aritzia-theratechnologies-et-le-cp/605516/2 Here is the translation : Theratechnologies (TH, $ 9.60): good results Canaccord Genuity reiterates a purchase recommendation. In the third quarter, the company reported revenues of $ 17.7 million and a profit of zero cents per share, compared to a house expectation for revenue of $ 17.2 million and a loss of $ 0.01. Dewey Steadman is pleased with the company¡¦s results as sales from Trogarzo and Egrifta allow the company to achieve positive earnings before interest, taxes, depreciation and amortization (EBITDA). He is impressed by the progress made by insurers. Trogarzo, its new product for people who have become resistant to existing HIV medications, is now covered for 195 of the 283 million lives insured, a rate of 69%. He said that the company¡¦s goal is to reach a penetration rate of 80% in the coming months. The analyst points out that the product is under experimentation among physicians and that management expects it to peak in the next four to five years. The target is $ 15. Reply Quote Add Post To Favorites Follow Post Report Abuse New Post « Older Post View All Posts Read more at www.stockhouse.com/companies/bullboard/t.th/theratechnologies-#Vdfj8xuwSDxbTIww.99 |
|
|
·|û¡GÀH½t¦Û¦b10147011 µoªí®É¶¡:2018/10/7 ¤W¤È 11:28:20²Ä 4017 ½g¦^À³
|
³B¤èÅÒªº¶}¥X¡A¦³85%¨Ó¦Û¤£¦PªºÂå¥Í¡I ³oÓ°T®§´¦ÅS¡A¥O¤H®¶¾Ä¡I |
|
|
·|û¡GÂyªÌ10142287 µoªí®É¶¡:2018/10/7 ¤W¤È 10:58:21²Ä 4016 ½g¦^À³
|
ÁöµM¦³¥~¸êɨé½æ³æ¤´µM«ùÄò¡A ¦ý¤¤¸Î¦b¤½§i¤E¤ëÀ禬«á¡A ³oÓ¬O°ê¤º³Í°ò§ëÅUµoªº¬ã¨s³ø§i¡A ¥[´î°Ñ¦Ò¡A ¤é´Á: 2018¦~10¤ë3¤é GMT+8 ¤W¤È8:00:20 ¦¬¥ó¤H: undisclosed-recipients:; ¼ÐÃD: ¤¤¸Î (4147.TW/4147 TT): º¥¤J¨Î¹Ò ¤¤¸Î (4147.TW/4147 TT): º¥¤J¨Î¹Ò ¬ã¨sû¡G·¨¤S¿o «n°T®§ ¤¤¸Î¤½§i9¤ë·~ÁZ¡AÀ禬3,701¸U¤¸¡A¤ë¼W59%¡C3Q18À禬Á`p7,332.9¸U¤¸¡A¸û«e¤@©u¦¨ªø¤@¿¡AÀ禬ªí²{²Å¦X³Í°ò¹w¦ôªº7,200¸U¤¸¡C µû½×¤Î¤ÀªR ¤µ¦~©³«eTrogarzo¦b¦h«§ÜÃÄ©ÊHIV¯f±wªºº¯³z²v¥i±æ¹F10%¡C 9¤ëÀ禬3,701¸U¤¸¡A¤ë¼W59%¡A·N¨ýµÛTheratechnologies (¥[) qÁʤF¹O3¤d¾¯Trogarzo¨Ñ¯f±w©ó10¤ë¨Ï¥Î¡C¤¤¸Î©M¦æ¾P¹Ù¦ñTheratechnologies (¥[) ¹F¦¨¨óij¡A¦Û7¤ë°_¥H¨C¤ë¤@¦¸ªº¤è¦¡qÁÊTrogarzo¡A¦]¦¹¤¤¸Îªº¤ëÀ禬ªí²{»PTheratechnologies¹w¦ôªºTrogarzo¨C¤ë¥Î¶q®§®§¬ÛÃö¡C¨Ì¾ÚTrogarzoªº¼Ð¥Ü¡A¤@¦W¯f±w¨CÓ¤ë¦Ü¤Ö»Ý¨Ï¥Î¤K¾¯¡A´«ºâ¤U¨Ó¡A¥Ø«e¦ôp¦³¶W¹L300¦W¯f±w¨Ï¥ÎTrogarzo¶i¦æªvÀø¡CY¦¨ªø³t«×ºû«ù¤£ÅÜ¡A¹wp¤µ¦~©³Trogarzoªº¨Ï¥Î¤H¤f´N·|¬ð¯}1,000¤H¡A±µªñTrogarzo ªvÀøªº¥Ø¼Ð±Ú¸s (§Y50%¦h«§ÜÃÄ©ÊHIV¯f±w¡A¬ù12,000¤H) Á`¼Æªº10%¡C Y¦¨ªø°Ê¯à¤£ÅÜ¡A«h2018¦~À禬¥i±æ¹F¦¨¬ã¨s³¡¹w¦ôªº3.18»õ¤¸¡C ¦Û7¤ë¥H¨Ó¤¤¸ÎÀ禬§¡ºû«ù¤ë¼W¹O50%ªººA¶Õ¡A¤Ï¬M¦æ¾P¹Ù¦ñTheratechnologies§ó¥[¼ô¸Z¦æ¬Fµ{§Ç¡A¶V¨Ó¶V¦h«OÀI¾÷ºc±NTrogarzo¯Ç¤Jµ¹¥I½d³ò¡A¦Ó¨äÀø®Ä¤]¤wÀò±oÂå¬ÉªÖ©w¡C³Í°ò¹w¦ô¥HÀ禬¤ë¼W50%ªº´T«×±Àºâ¡A2018¦~¤¤¸Î¾ãÅéÀ禬±N¶¶§Q¥i¹F¦¨³Í°ò¹w¦ôªº3.18»õ¤¸¡C §ë¸ê«Øij §Ú̬ݦnTrogarzoªºº¯³z²v¤W¤É¡A¥B¦¨ªø°Ê¯à±Nºû«ù¤£¼Y¡A¦]¦¹ºû«ù¤¤¸Î¡u¼W¥[«ùªÑ¡vµûµ¥¡A¥Ø¼Ð»ù312¤¸¡C §ë¸ê·ÀI µLªkÂX¤j¥«¦û²v¡B¥Í²£·ÀI¡C |
|
|
·|û¡G¹A¤Ò10147224 µoªí®É¶¡:2018/10/6 ¤U¤È 06:41:19²Ä 4015 ½g¦^À³
|
¦ý¤£ºÞª¦²L¤s©Î²`¤s ¦Û¤vªºÅé¤Oª¬ªp³£¬O«n¦Ò¶q ¹w¯¬¤j®a ª¦¤s¶¶§Q ¥¦w§Ö¼Ö¦^®a |
|
|
·|û¡G¹A¤Ò10147224 µoªí®É¶¡:2018/10/6 ¤U¤È 06:34:08²Ä 4014 ½g¦^À³
|
Yª¦²L¤s¡AÀ³¥un¦Ò¼{ªñ¤é¤Î·í¤é®ðÔ´N¦æ¤F Ynª¦¦Ê©¨¡A«h´Nn·V«µû¦ô¤F |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/5 ¤U¤È 10:55:11²Ä 4013 ½g¦^À³
|
¹A¤Ò¤j§Î®eªº·¥¦n¡I ----- ·Rª¦¤sªº¤H ¦Û¨¸Ë³Æ¥in»ô¥þ¡A¨Ã¶·¦³·¥°ªªº¦w¥þ·NÃѤÎÂ×´Iªº®ðÔÆ[´ú¯à¤O ÁÙ¦³ »ä·¤Ñ¡B¦a¾_¡B»¨¤j«B®ðÔ¡AÀ³ÁקK¥hª¦¤s ----- ¦Ê©¨ n¤U¤s¡A¤]¦³¦n´XºØ¤è¦¡¡A ¤@ºØ¬O¦³¥ý¶R«OÀI²¼¡A¶¶§Q¤U¤s¡]½æªºº}«G¡A¥[¨éªÅ¡^ ¤@ºØ¬O§x¦b¤s¤W¡A¤£«H¨¸¶ÃºN¶Â¤U¤s¡]¤@¸ô¶ÃÅu¥¡^ ³Ì¯S®íªº¬O¶Ãcall ±ÏÃøª½¤É¾÷¤U¤s¡A¦ýÁÙnÃB¥~ªo¥I¿ú¡]¦hªÅÂù¤Ú¥[¤WÂ_ÀY¡^ ¥xÆWªº¤s¡AÁÙ¬On¦³±M·~ª¾ÃÑ¡A¸ò°í©wªº¼Ý¤O¬ö«ß¡A¤~¦nÃkµn°Ú.... ªàµæÁ¿Á¿¡A³Õ§g¤@¯º |
|
|
·|û¡GChang252810146909 µoªí®É¶¡:2018/10/5 ¤U¤È 10:47:51²Ä 4012 ½g¦^À³
|
Trogarzo can be prescribed in France under a special access program for some unapproved drugs with clear clinical benefit. Number of patients will certainly be very low, but as for the EAP in the US, it bodes well for Europenan approval. There is a real need for this drug. |
|
|
·|û¡G¦n¹B10137114 µoªí®É¶¡:2018/10/5 ¤U¤È 09:08:16²Ä 4011 ½g¦^À³
|
°ê®õ¥Á¦w¤j ÁÂÁ¡Cɨ÷§Q²v¨S¦³¸û°ª¡A¥i¥H¤¤©Ê¸ÑŪ¡C ɨ÷ÄÝ¥¿±`ªºÁ×ÀI¡AÀ³¸Ó¤£¬O¹ï¥¼¨Ó¬ÝªÅ¡C |
|
|
·|û¡G¹A¤Ò10147224 µoªí®É¶¡:2018/10/5 ¤U¤È 07:38:39²Ä 4010 ½g¦^À³
|
³oªi¥xªÑ¬Û·í¯S§O ¦b¥«³õ¤W ³Ð³y¤F¦Ê©¨°ª¤s ·Rª¦¤sªº¤H ¦Û¨¸Ë³Æ¥in»ô¥þ¡A¨Ã¶·¦³·¥°ªªº¦w¥þ·NÃѤÎÂ×´Iªº®ðÔÆ[´ú¯à¤O ÁÙ¦³ »ä·¤Ñ¡B¦a¾_¡B»¨¤j«B®ðÔ¡AÀ³ÁקK¥hª¦¤s |
|
|
·|û¡G¹A¤Ò10147224 µoªí®É¶¡:2018/10/5 ¤U¤È 07:22:58²Ä 4009 ½g¦^À³
|
¥xªÑ¦ì©ó¼Ú¨È¸êª÷ªO¶ôÀ½À£ ¥«³õ¦a´ß·¥¤£Ã©w ¨ì³B²£¥Í³y¤s¹B°Ê ¹M¦a¤j¤s¶©°_ ¤p¤ß§r ¦a´ß¤w¯Ü®z¤F |
|
|
·|û¡G°ê®õ¥Á¦w10141426 µoªí®É¶¡:2018/10/5 ¤U¤È 07:02:47²Ä 4008 ½g¦^À³
|
ÃÒ¨÷°Ó¦³¥´¹q¸Ü°Ý§Ú¡Aɨ÷ªº§Q²v¬O1.5%,§Ú¨SÉ |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/5 ¤U¤È 01:38:38²Ä 4007 ½g¦^À³
|
·PÁ¤À¨É <<®Ö²a¬yµ{¬ùÁYµu¤F17¤Ñ¡C85%¤j³¡¥÷¯f¤H¥Ñ¤£¦PÂå¥Í¶}¥X¡A¥LÌ¥¿¦bÆ[¹îÀø®Ä¡C>> ³o¥y¸ÜÓ¤H»{¬°À³¸Ó¬Û·í«n §Ú¤£·Q»¡¥ô¦ó¼ÖÆ[ªº¦r²´¡A¦ý¼f·VÆ[¹î¡C ²¦³º¥xªÑ²LºÐ¡A¶T©ö¾Ô¥[ºt²ß¥[¨S«H¤ß¡A¥xªÑ¤@°ï¹q¤lªÑ¤w¸g¶^¨ìµ}¤ÚÄê¡C »¡¦Ñ¹ê¸Ü¡AÆZ¦hªÑ²¼³£¦³ÂI¹³´Á³f¤@¼Ë¡Aªi°Ê·¥¤j¡A¹³½ä³õ¤@¼Ë... »sÃĥͧÞÁÙºâ¬Û¹ï¤£¨ü¶T©ö¾Ô¼vÅTªº±Ú¸s¡A¥u¯àÄ~ÄòÀR¤ß ¦@«j¤§ |
|
|
·|û¡G¦n¹B10137114 µoªí®É¶¡:2018/10/5 ¤U¤È 01:30:06²Ä 4006 ½g¦^À³
|
Meng¤j ½Ð°Ýɨ÷ªº§Q²v¹q¸Ü¤¤§iª¾¬O¦h¤Ö¡H§Ú¦³¸ß°ÝÀç·~û¦ý¥¼¦³É¨÷»Ý¨D¡C |
|
|
·|û¡GChang252810146909 µoªí®É¶¡:2018/10/5 ¤U¤È 01:23:25²Ä 4005 ½g¦^À³
|
·PÁ¶³¤j´£¨Ñ¡A¤jP¦p¤U¡A«OÀIÂл\¬ù75%¡C®Ö²a¬yµ{¬ùÁYµu¤F17¤Ñ¡C85%¤j³¡¥÷¯f¤H¥Ñ¤£¦PÂå¥Í¶}¥X¡A¥LÌ¥¿¦bÆ[¹îÀø®Ä¡C¦p®ÄªG©M¤T´Á¤@P«h±N«D±`¼ÖÆ[¡C¤U¤@©u¤´ºû«ù°Ê¯à¦ý¨S¦³¹w´Á喷¥X¡C静¯ßª`®g¦³ÂI¤p³Â·Ð¤§Ãþ¡C |
|
|
·|û¡G¶³²H·»´10146472 µoªí®É¶¡:2018/10/5 ¤U¤È 12:53:58²Ä 4004 ½g¦^À³
|
Edited Transcript of TH.TO earnings conference call or presentation 4-Oct-18 12:30pm GMT finance.yahoo.com/news/edited-transcript-th-earnings-conference-150738988.html |
|
|
·|û¡GJACKY WU10147205 µoªí®É¶¡:2018/10/5 ¤U¤È 12:46:40²Ä 4003 ½g¦^À³
|
¥Dn¬O´£¿ô¤j®aª`·N¡AÁקK³Q¦hªÅÂù±þ |
|
|
·|û¡G¶³²H·»´10146472 µoªí®É¶¡:2018/10/5 ¤U¤È 12:26:30²Ä 4002 ½g¦^À³
|
½u«¬¯uªº87¤À¹³, «¢. www.genetinfo.com/investment/featured/item/20431.html |
|
|
·|û¡G¦×©@10141509 µoªí®É¶¡:2018/10/5 ¤U¤È 12:17:43²Ä 4001 ½g¦^À³
|
ÁÂÁ¶³¤j |
|
|
·|û¡G¶³²H·»´10146472 µoªí®É¶¡:2018/10/5 ¤U¤È 12:12:00²Ä 4000 ½g¦^À³
|
¦P¼Ëªº¤å¦r, ªGµM²z¸Ñ·|¤£¤@¼Ë. §Úªº²z¸Ñ¬OJACKY ¤j§â¥Lªºµu³æ¥þ¥X¤F. |
|
|
·|û¡G¦×©@10141509 µoªí®É¶¡:2018/10/5 ¤W¤È 11:38:53²Ä 3999 ½g¦^À³
|
½Ð±ÐJACKY WU¤j ¦p¦ó¬Ý¥X¦½Lµu³æ¥þ¥X¤F? ¦³¬Æ»ò¬Ý½L³nÅé¶Ü ÁÂÁ |
|
|
·|û¡GJACKY WU10147205 µoªí®É¶¡:2018/10/5 ¤W¤È 11:17:44²Ä 3998 ½g¦^À³
|
·Qn¦bªÑ¥«ÁÈ¿ú¯u¬On´L«I«á¨º°¦µL¼v¤â¡A¨Ì§Þ³N½u«¬¦æ¨Æ§a! ¦½Lµu³æ¥þ¥X¤F!¤j®a¤p¤ß |
|
|
·|û¡GChang252810146909 µoªí®É¶¡:2018/10/5 ¤W¤È 11:11:40²Ä 3997 ½g¦^À³
|
¤Z¥´¤£¦ºªº¥²§ó°í±j! |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/5 ¤W¤È 11:01:44²Ä 3996 ½g¦^À³
|
«á¶Õ¥i¯àÁÙ·|¦³¾_Àú¡A¤j®aÁÙ¬On«ù¬Õ«O®õ ¦ý¬Û¤ñ¨ä¥L ¤µ¤Ñ4147 ¬Û¹ï¬O±jªº³á¡I |
|
|
·|û¡GPROTSAI10146704 µoªí®É¶¡:2018/10/5 ¤W¤È 10:59:13²Ä 3995 ½g¦^À³
|
Ô ¥xÆW¤H ¤£¬O¥s§A¦^´ú¤£¯}¦A±µ |
|
|
·|û¡G¦µ¶©°^10147391 µoªí®É¶¡:2018/10/5 ¤W¤È 10:25:12²Ä 3994 ½g¦^À³
|
¦³¥y¸Ü»¡¡AÂб_¤§¤UµL§¹§Z¡C ¤j½L§½¶Õ¦ü¥G¤£§®¡A«ù¦³³¡¦ì»Ýn¤p¤ß¡C |
|
|
·|û¡G¥xÆW¦10140942 µoªí®É¶¡:2018/10/5 ¤W¤È 10:05:31²Ä 3993 ½g¦^À³
|
ü~¦¤W§Ú§Ô¤£¦í¤S¥[½X3±i,µ²ªG²{¦b¤S..... ¯u¬O°Q¤£¨ì«K©y,µL©`~ |
|
|
·|û¡GBRN10138015 µoªí®É¶¡:2018/10/4 ¤U¤È 11:36:35²Ä 3992 ½g¦^À³
|
10/4 ¡]¥[®³¤j®É¶¡¡^ TH¦n¹³¬On¥l¶}²Ä¤T©u°]³ø·|ij? ¶}©l¤F¶Ü? |
|
|
·|û¡GChang252810146909 µoªí®É¶¡:2018/10/4 ¤U¤È 11:29:39²Ä 3991 ½g¦^À³
|
Jacky¤jºâ±o¦X²z¡A¥[®³¤j¨º¦ì¤w¸g¦b³Qk¤F¡A§Ú¤]ºâ¬O¨ü®`ªÌ¤F¡A«¢«¢¡A¤ß±¡ÃP¤F³\¦h¡C²¦³º¤~¤S¸õ¤U¥h¡A¨B¨BÅå¤ßªº!ÁÙ¦n§Ú¦³¥ÎºÃ°Ý¥y! |
|
|
·|û¡GÂyªÌ10142287 µoªí®É¶¡:2018/10/4 ¤U¤È 11:26:49²Ä 3990 ½g¦^À³
|
Ô£¦Ì⋯, °ª峯¾P°â¯f±w2000¡ã3000¤H¡A ¨ºÂy¤H²q©ú¦~©³´N¹F¼Ð¤F¡A ¤H®aºô¤Í¸É·®»¼vªº¨¥½×¡A¤]¶K¥X¨Ó¡A «¢«¢¡A¡u¶ÂÀs¦è®à¡v ÁÙ¬O¥h¬Ý¬ÝªÑªF·|¤Î¥H«e¤¤¸Îªk»¡·|¡A ±i©À츳¨Æªøªº¹w´ú¡A ¨C¦~¶·´«ÃĪº12500¦UMDR¯f±w¡A ¤¤¸Î¥Ø¼Ð¹wp®³6000¡ã7000¤H¡A ¦ÓÃB¥~«DMDR¯f±w¦³ªñ30000¤H¡A ¤]³\¦³³¡¥÷¥i¾A¥Î¡A «O¦uªº¦ôp¡A¤j¬ù¦p¦¹Åo¡I |
|
|
·|û¡GJACKY WU10147205 µoªí®É¶¡:2018/10/4 ¤U¤È 11:23:54²Ä 3989 ½g¦^À³
|
Chang¤j ¨ä¹êºâªkÄAˤF¡A¥¿½Tºâªk¬OTrogarzo(5000-7500¤H)/4-5¿=Egrifta1000-1875¤H¼Æ¤~¹ï |
|
|
·|û¡GÀH½t¦Û¦b10147011 µoªí®É¶¡:2018/10/4 ¤U¤È 11:22:45²Ä 3988 ½g¦^À³
|
¥Ø«e³£¤w¸g¦³¤T¨Õ¦h¤H¦b¨Ï¥Î¤F¡Ipeak sales ¤£¥i¯à¬O2500¤H¡A¤j®a¤£nºò±i¡I |
|
|
·|û¡Gvito10147056 µoªí®É¶¡:2018/10/4 ¤U¤È 11:22:28²Ä 3987 ½g¦^À³
|
¤£nÀ~¤H°Õ ®Ú¥»¨S»¡¤H¼Æ |
|
|
·|û¡GJeff10147295 µoªí®É¶¡:2018/10/4 ¤U¤È 11:17:33²Ä 3986 ½g¦^À³
|
¦U¤j¤j¡A ˬOTH ¦A¦¸¹L2¦ì¼Æ¡A¹ï4147²£¥Í¦ó®ÄÀ³¡H |
|
|
·|û¡GChang252810146909 µoªí®É¶¡:2018/10/4 ¤U¤È 11:17:16²Ä 3985 ½g¦^À³
|
§Ú¤]¬O»{¬°¤£¤Ó¦X²z¡A¬Ý¨ì®ÉÀ~¤F¤@¸õ¡AÁÂÁ¦U¦ì«ü¥¿! |
|
|
·|û¡GBRN10138015 µoªí®É¶¡:2018/10/4 ¤U¤È 11:11:10²Ä 3984 ½g¦^À³
|
TH¤U×°ª®p¥Ø¼Ð¤H¼Æ¬°2000-2500¤H? TH 11:00ªÑ»ù9.7¤¸¤jº¦13% Y°T®§¬O¤½¥qµo§Gªº¡AÀ³¸Ón¤j¶^50%¤~¦X²z§a ! ¤~è¶}©l¾P°â¡A´N°¨¤W¤j´T¤U×°ª®p¥Ø¼Ð¤H¼Æ¡A¥i¯à©Ê¤£°ª§a ! |
|
|
·|û¡GChang252810146909 µoªí®É¶¡:2018/10/4 ¤U¤È 11:10:59²Ä 3983 ½g¦^À³
|
Luc¦³»¡¥Ø¼Ð¬Oegriftaªº4-5¿¡A±À¦ô§Y¬O2000-2500¡C¤£´±¨¥§Ú¹ï¿ù¡A¥u¬O³o两®a¤½¥qÁ¿¸Ü«¥Á`¸ò¦b²qÁ¼¦üªº¡A©Ò¥H¤~n¶°«ä¼s¸q¡Cťť¦U¦ì¤j¤j«ç»ò¬Ý! |
|
|
·|û¡GJeff10147295 µoªí®É¶¡:2018/10/4 ¤U¤È 11:09:27²Ä 3982 ½g¦^À³
|
¦U¤j¤j£´ ¡×¡×¡×¡×¡×¡×¡×¡×¡×¡×¡×¡×¡×¡×¡× ¬Ý¿ù?TH¤U×°ª®p¥Ø¼Ð¤H¼Æ¬°2000-2500¤H¡C®É¶¡×¥¿¬°3-5¦~¡C³o¼ËTH²{¦b¤jº¦?¬O§Ú̪º´Á±æ¤Ó°ª? ¡×¡×¡×¡×¡×¡×¡×¡×¡×¡×¡×¡×¡×¡×¡×¡×¡× ¤Wz¥[®³¤jª© JerryL ¥ß°¨¾DSpeco1 ªÈ¥¿¡A¦] JerryL¨SÅ¥²{³õcall ¬Ý³ø¬£news¦Ó¤w¡I |
|
|
·|û¡Gmengs10146592 µoªí®É¶¡:2018/10/4 ¤U¤È 11:03:04²Ä 3981 ½g¦^À³
|
Chang¤jÀ³¸Ó¬Ý¨Óªº¡A§Ú¥´¥h°Ý§ÚªB¤Í¥L»¡Luc¥u¦³¥ÎEgrifta¥h±ÀTrogarzo¡AÄÀ©úTrogarzo·|¤ñEgrifta±j¡A¹ýÀY¹ý§À¨S´£¨ì¤H¼Æ¡C §Ú¦ôp³o¤H¼Æ¬O¥[®³¤jºô¤Í¥ÎLucªº¸Ü¡A¥h±À¾Éªº¡Aťť°Ñ¦Ò´N¦n¡I |
|
|
·|û¡G¶³²H·»´10146472 µoªí®É¶¡:2018/10/4 ¤U¤È 11:01:44²Ä 3980 ½g¦^À³
|
¥u¬O¬Y¦ìºô¤Í¦Û¤v¦ôªº¡A¦A¥h°Q½×°Ï¬Ý§a¡I |
|
|
·|û¡Gªü¤¤10143502 µoªí®É¶¡:2018/10/4 ¤U¤È 10:59:53²Ä 3979 ½g¦^À³
|
½Ð°Ý¤j¤j,³o¬OTH¤½¥q»¡ªº¶Ü? ÁÙ¬Oºô¸ôTHªº°Q½×ª©¬Ý¨Óªº |
|
|
·|û¡G¬K©M´º©ú10141799 µoªí®É¶¡:2018/10/4 ¤U¤È 10:59:42²Ä 3978 ½g¦^À³
|
TH¤U×°ª®p¥Ø¼Ð¤H¼Æ¬°2000-2500¤H ³o¼Ë355¥¼¨Óµ¦²¤´N«Ü©ú½T¤F¡Anº¦»ù¨«°ª»ù©t¨àÃĸô½u¤F ¨u¯fÃĪ««O»Ù³Ð³y¶W°ªÃÄ»ù¡AÃļtÅDÀsªù®aÄݳ´¿ú§|¡H technews.tw/2014/10/22/a-drug-regrew-a-little-girls-missing-bones-how-much-should-that-cost/ ³o½g¥i¥H¬Ý¨ì¨ä¥L©t¨àÃĬO¦p¦ó¥Î°ªÃÄ»ùÁÈ¿ú ¥t¥~¤j®a·|¾á¤ß°ªÃÄ»ù¹ï©ó¯f±wªºt¾á ¸Ì±ªº ¥«³õªº¡u¼ç³W«h¡v ³o³¡¥÷¦³»¡©ú ®Ú¥»¥I¤£°_¡A³sÂåÀø«OÀI³£¨S¦³ªº±wªÌ¡AÃļt±`±`ºB´nªºÃØÃÄ¡A°µ°µ¤½Ãö¡A©Î¬O¦¬¨ú¶H¼x©Êªº¶O¥Î¡A¦h¤ÖÁȤ@ÂI¡C °l¨D³Ì¤j§Q¼íªºÃļt¡A¹ê»Ú¤W¬O·Q¿ìªk±q´I¤H¨¤WÁȨú³Ì¦h¿ú¡A«o¥H§C·G»ù®æµ¹¤©½a¤H¥ÎÃÄ¡Aµ¥©ó¬O¡u§T´IÀÙ³h¡v¡C ¹ï©t¨àÃĨӻ¡¡AnÁÈ¿ú¡A¤H¼Æ¤£¬O«ÂI ´N@¤ßµ¥«Ý¤¤¸Î¤½¥q¦ó®É·|¥Î¤W©t¨àÃĪºÅ@¨²Å¡A¶}±Òº¦»ùªºµ´©Û ¹³Soliris¤@¦~50¸U¬ü¤¸¤W¤U¡A»¡¯uªº¨S´XÓ¤H¥I¾á±o°_ SolirisÁÙ¬O¨C¦~¦n´X»õ¬ü¤¸¦bÁÈ ¨ä¥L¯f±w¤H¼Æ¤Öªº©t¨àÃĤ]¬O¨C¦~¦n´X»õ¬ü¤¸ªºÀ禬 ¤¤¾óªvÀøÃe¨©¤ó¯gªºMyozyme¡AÃÄ»ù¤]¬O°ª¹F¨C¦~30¸U¬ü¤¸ |
|
|
·|û¡GChang252810146909 µoªí®É¶¡:2018/10/4 ¤U¤È 10:50:37²Ä 3977 ½g¦^À³
|
°ÝÃD¬O¦pªG°ª®p¥Ø¼Ð¥u¦³2500¡A¨º¤§«e¸Î¤Í̪º±Àºt¼Ò¦¡¥þ³¡«¨Ó¡A²Ä¤@¦~¬°®pȪº20%.¥[¤W¤¤Â_²v¦Ò¼{¶i¨Ó¡A¨º²Ä¤@¦~³B¤èñ¤j¬ù1000¡C°]°Èªøªº¹w测¤£ÅܬO¦ó·N?¦~©³¯}¸U²~ªGµM»¡ªº¤£¬O¤µ¦~©³?Ãø©Çɨ骺Áx¦p¤Ñ¤j! |
|
|
·|û¡Gmengs10146592 µoªí®É¶¡:2018/10/4 ¤U¤È 10:42:52²Ä 3976 ½g¦^À³
|
1 THªÑ¥»¤ñ¤¤¸Î¤p¡A³æ´N355³o¶µ²£«~±a¨Óªºeps¦Ó¨¥¡A¥L̪ѻù¤ñ¤¤¸Î°ª«Ü¦X²z 2 ¤¤¸Îªº»ùȦb©ó¾ãÓpipeline¡A¦ÓTH»ùȦb©ó³oÀɦ¨¥\·|¦³¤U®a¼t°Ó§ä¥L̽æÃÄ¡A©Ò¥H¥HªÑ»ù±À¤É°Ê¤O¨Ó»¡¡A¤¤¸ÎªÑ»ù»Ýn·Q¹³¤O¡]¦]¬°¬O¬ã¨s¾÷ºc¡^¡A¦ÓTHªÑ»ù»Ýn¯uª÷¥Õ»È¤J±b¡]¦]¬°¬O¾P°â¾÷ºc¡^¡A¤¤¸Îªº¦X²z»ù¤]¤£¬O355ªºpeak sale¥h±À´N·Ç¡A¦]¬°¦pªG¬O³o¼Ë¡A¨º355¤W¥««e¤¤¸Î¤£´N¤@Ó³¾¤ò³£¤£È¡H¥²¶·§â«áÄò²£«~ªºI II III´Á»ù®æµû»ù¤]¦Ò¶q¶i¥h¡A¦ý¤@¯ë¤H¤£·|ºâ³o»ò¦h¡A¤]¨S³o»ò²z¸Ñ¡A¨º´N¦b§CÀɦh¶RÂI¡A¥u¯à³o¼Ë¡C 3 ¦p¦P´X¤Ñ«e©ÒÁ¿¡A¤£n¦AÃhºÃ¤F¡A¨S¦³ÃÄ®`¡A°ª¼h¨S¥Xª¬ªp¡A¤½¥q¨S¥Xª¬ªp¡AªÑ»ù¤£·|¥¥ÕµL¬G¤ÏÀ³¡A´N¬O±þÀ禬¡A¦Ó§Ú»{¬°À禬ÃD§÷¤w¸g¤ÏÀ³®t¤£¦h¡A¤]´N¬O»¡§Ú»{¬°³o¦¸ªºTH´£¨Ñ¼Æ¾Ú¶H¼xµÛ§Ú̵¥«Ü¤[ªº§QªÅ²×©ó¥X²{¤F¡A2500¤H´N2500¤H§a¡A¦]¦¹¤£¬Ý¦nªº¥i¥HÂǦ¹¥X±¼¡A¯d¤U¨Óªº¡A¥i¥H¶}©l¼fµø«áÄò²£«~¶i«×¤F¡C 4 §Þ³N±¨S³o»ò²³æªº¡A¸õªÅ¯Ê¤f¦^¸É¡B»ù¶^¶qÁY³oºØ¸ô¤H¬Òª¾ªºªF¦è°ò¥»¤W§¹¥þ¨S°Ñ¦Ò»ùÈ¡A¦n¤ñ¦pªG§A¬O°ò¥»±¬£¡A¦ý¥uÁ¿±o¥X¥»¯q¤ñ¨º§A´Nµù©w³Q´£´Ú¡AµL»Ý¹w³]¥ß³õ..§Ú¤]¤£¤è«K±Ð¾Ç¤Ó¦h¡A¦ý§Ú¥u¯à»¡ÅãÅS±Ñ¶H«e¡AµL»Ý¦Û¤vÀ~¦Û¤v¡C 5 Jeff¤j©p»¡UMC TSMC¡A³o¨Ç§A¥h¨CӪѲ¼°Q½×°Ï³£·|¦³ªº°ÝÃD¡AþÓ°Q½×°Ï¤£¬O§â¸ÓªÑÁ¿±o¸ò¯«¤@¼Ë«¢«¢¡H¦Ü©ó§A»¡¤£¯à©MmlccÃþ¤ñ¡A³oÂI¨p¥H¬°¦³¹ï¦³¿ù¡A¹ïªº³¡¤À¬O¡A¥»¨Ó´N¤£¯àª½±µÃþ±À¡A¥Í§ÞªÑ©¹©¹¥i¥H¦b¥«³õ¤W¬¡¤[¤@ÂI¡A³o¤]¬O¥»¯q¤ñµ¹°ªªºì¦]¡]¤£¬O¬Ý¤ß±¡¶Ãµ¹ªº¡^¡F¿ùªº³¡¤À¬O¡AªÑ»ù¥Ã»·¨«¦b«e¡A«Ü¤Ö¦³¨Ò¥~¡A¤]´N¬O»¡¦pªG4147¥u¦³355³o²£«~¡Apeak sale§A¤~½æªÑ²¼¡A§Ú¥]·Ç§A®M¨ì²`³BµL«è¤×¡A¤£¹L¦n®a¦b¦³§¹¾ãªºpipeline¡A·í355ÃD§÷¥Î¥ú®É¡A¦pªG«áÄò²£«~¯à±µ¤W¡A¨º©Î³\³o¤äªÑ²¼¯uªº¥i¥H¨«¦n´X¦~ªº¦æ±¡¡C |
|
|
·|û¡GChang252810146909 µoªí®É¶¡:2018/10/4 ¤U¤È 10:16:56²Ä 3975 ½g¦^À³
|
§Ú¬O§_¬Ý¿ù?TH¤U×°ª®p¥Ø¼Ð¤H¼Æ¬°2000-2500¤H¡C®É¶¡×¥¿¬°3-5¦~¡C³o¼ËTH²{¦b¤jº¦?¬O§Ú̪º´Á±æ¤Ó°ª? |
|
|
·|û¡GJeff10147295 µoªí®É¶¡:2018/10/4 ¤U¤È 09:55:03²Ä 3974 ½g¦^À³
|
mengs¤j¡A |
|
|
·|û¡G¹A¤Ò10147224 µoªí®É¶¡:2018/10/4 ¤U¤È 08:28:32²Ä 3973 ½g¦^À³
|
«z¡AÁÙ³o»ò¦h¤H¦b·m¦^·l¥¢§V¤O¤¤ ¤£¦ûª©±¤F ·m¦^¦h¤Öºâ¦h¤Ö ¦ý¤@©wn¦w¥þ¤U¼Î |
|
|
·|û¡GJeff10147295 µoªí®É¶¡:2018/10/4 ¤U¤È 08:26:05²Ä 3972 ½g¦^À³
|
¦µ¤j¡A ¥ÎÃÄ«áfollow-up ¥HÁקK¥¼«ö®É«ö¤é¥hÂå¥Í¶E©Ò¥´°w¡]ݤF¸Ñ¥ÎÃÄ«á¨Å骬ªp¡^¦]¦Ó²£¥Íªº§ÜÃÄ©Ê ¡]¥ÍÂA¤jªºÄ¶¤å¤º¡ã¦p±wªÌ¤£¨Ä §Yadherence¤£¨Î©Ò³y¦¨¡^¡A¤H©RÃö¤Ñþ¡I¡]miss one dose may occur¡^ ©Ò¥H»ÝnTH ¯àª`·N¤Î¨CÓ±wªÌÓ§Oneed follow-up one by one, right? «D«ü¥b¦~«á ·|¦³¦h¤Ö¤ñ²vªº¥ÎÃĪ̲£¥Í§ÜÃÄ©Ê¡A³o¹L«×¸ÑŪ°Õ¡I |
|
|
·|û¡G¶³²H·»´10146472 µoªí®É¶¡:2018/10/4 ¤U¤È 08:12:27²Ä 3971 ½g¦^À³
|
The third quarter of 2018 represents the first full quarter of sales for Trogarzo™ as it only became commercially available on April 30, 2018. For the third quarter of 2018, Trogarzo™ revenues amounted to $4,864,000 or US$3,713,000. |
|
|
·|û¡G¤p³½10141408 µoªí®É¶¡:2018/10/4 ¤U¤È 08:08:31²Ä 3970 ½g¦^À³
|
Theratechnologies Announces Financial Results for the Third Quarter of 2018 www.stockwatch.com/News/Item.aspx?bid=Z-C%3aTH-2666825&symbol=TH®ion=C |
|
|
·|û¡Gvito10147056 µoªí®É¶¡:2018/10/4 ¤U¤È 07:40:59²Ä 3969 ½g¦^À³
|
©Ô¦^n¶qÁY ¥Ø«e¤©P¥§¡½u¨«¥n©¹¤W©Ô¤F... ©Ô¦^¤£n¶^¯}5©P¥§¡½uªº®É¶¡¤Ó¤[ À³¸Ó¥i¸ÑŪ¨«¦h |
|
|
·|û¡GPROTSAI10146704 µoªí®É¶¡:2018/10/4 ¤U¤È 06:41:44²Ä 3968 ½g¦^À³
|
_____________________ Ãø¹D194¯Ê¤f¤£¸É-.- _____________________ §Þ³N¤ÀªR¨S¬Æ»ò¤@©w¤£¤@©w ¶È¨Ñ°Ñ¦Ò ¤Wz³o¼ËÁ¿¸ò²Ä¥|¥x¦Ñ®v¤@¼Ë....... ¥~¦æ |
|
|
·|û¡Gyu76021610146652 µoªí®É¶¡:2018/10/4 ¤U¤È 06:08:40²Ä 3967 ½g¦^À³
|
Ãø¹D194¯Ê¤f¤£¸É-.-§O¤Ó¼ÖÆ[......¦^180¦b¨«¨«©Î³\¦n¤@ÂI |
|
|
·|û¡GPROTSAI10146704 µoªí®É¶¡:2018/10/4 ¤U¤È 06:03:50²Ä 3966 ½g¦^À³
|
¤é½u»P¤ë½u¶Àª÷¥æ¤e ©u½u»P¦~½u¦º¤`¥æ¤e ¦³½ì¤F ¤w¬ð¯}¤U°ÁͶսu ©Ô¦^¤£¯}¤¤é½u «h.......¦Û¦æµû¦ô·ÀI |
|
|
·|û¡G¦µ¶©°^10147391 µoªí®É¶¡:2018/10/4 ¤U¤È 05:22:04²Ä 3965 ½g¦^À³
|
Ãö©ó§ÜÃĩʳoÓ°ÝÃD¡C ¡u²z½×¤W¡v¤£·|¨º»ò§Öµo¥Í¡A¤j³¡¤Àªº¯f¤H¤~¨Ï¥Î¥b¦~¤£¨ì¡F n¬O³o»ò§Ö´N°ª¤ñ¨Òªº¯f¤H¦³§ÜÃÄ©Ê¡A°O±o¥X²M¦s³f¤@±i¤£¯d¡C ¶¶«K¤Ï¤âªÅ¤@¤U¡C ¼ÖÆ[¬Ý«Ý¡A«ùÄòÆ[¹î¡C |
|
|
·|û¡GJeff10147295 µoªí®É¶¡:2018/10/4 ¤U¤È 05:00:22²Ä 3964 ½g¦^À³
|
Aha ¦µ¤j¤j¡A ¦µ¤j¡ã»~·|¬O¤j¤F¨Ç¡A§Ú¤]ª¾no prescription no medicine, ©Ò¤]¦UÃħ½¡K §Ú¤ñ³ë¡mçE³f¡n§¹¦¨·N«ü³£¨£±oµÛTrogarzo °Õ¡I §Ú»{¬°³o¥Nªí FDA ºÞ¨Æ +NEJM ºÞ¥Î¡A±µ¤U¨Ó ´N¬Ý Âå¥Í·Ý̶R¤£¶R±b°Õ¡I ¸Ü説 º¯³z²v¡]«OÀIÂл\²v¡^©Ô°ª¦Ü90%¥H¤W«n©O¡H ©Î TH§L¤O¥çÀ³³¡¸p©ó¥ÎÃÄ«áfollow-up ¥HÁקK²£¥Íªº§ÜÃÄ©Ê¡A ¤H©RÃö¤Ñþ¡I |
|
|
·|û¡G¦µ¶©°^10147391 µoªí®É¶¡:2018/10/4 ¤U¤È 04:32:23²Ä 3963 ½g¦^À³
|
µù¸Ñ¤@¤U¡FÃö©ó¡u´¶®³¯k¡v¡A§Úªº·N«ä¬O«D³B¤è¥ÎÃÄ¡C |
|
|
·|û¡G¦µ¶©°^10147391 µoªí®É¶¡:2018/10/4 ¤U¤È 04:18:31²Ä 3962 ½g¦^À³
|
«u§r§r¡A³oÓ¤£¬O¾Q³f°Õ¡C °ò¥»¤W¥i¥H³o¼Ë·Q¡C ÃĦ³°â»ù¡A¤£ºÞ¦³¨S¦³²{³f¡AÁÙ¬O¥i¥H§â³oӼлù¦C¥X¨Ó¡C µM«áscriptsave´N¬O¦Aµ¹¤@¨Ç§é¦©¡F§Ú²q´ú¬O¨Ì·Ó¼Ð»ù¼¤W¨CÓÃĩФ£¦Pªº§é¦©¡C ³oÃä¬d¨ìªº¬O¦³¨º¨ÇÃĩиòscriptsave¦³¦X§@¡A´£¨Ñ¤F§é¦©»ù®æ¡C °ò¥»¤W¡A¦³³B¤èñ¡A¦b¬ü°êªºÃĩШì³B³£¥i¥H¶R±o¨ìÃÄ¡F¨S¦³³B¤èñ¡AªÖ©w¤£·|¦³ÃÄ¡C §O¥h¾á¤ß¾Q³fªº°ÝÃD¤F¡C §Ú¥i¥H«OÃÒ¡A¥un¦³³B¤èñ¡A©Ò¦³Ãĩг£¥i¥H¶R¨ìTMB-355. §ÚÁÙ¥i¥H«OÃÒ´Nºâ®³µÛTMB-355ªº³B¤èñ¨«¶iÃĩСAÃĩЪ֩w³£¨S³oÃÄ¡Anq¡Aµ¥«Ý¤@¨â¤Ñ¤~¦³³f¡C |
|
|
·|û¡GPROTSAI10146704 µoªí®É¶¡:2018/10/4 ¤U¤È 02:45:38²Ä 3961 ½g¦^À³
|
ÂåÃĤÀ·~ Ãħ½³c°â (¨Ìªk)¶·¦³Âå®v³B¤èºà ,¬ì¬ì¬ì , §A¦b¥xÆWÃħ½¤]¤j·§¶R±o¨ì³B¤èÃÄ , ·íµM¦p°ê¯f¤H¨ú±o¤è«K ¨º¹ï¤¤¸Î GOOD |
|
|
·|û¡GJeff10147295 µoªí®É¶¡:2018/10/4 ¤U¤È 02:30:35²Ä 3960 ½g¦^À³
|
¦µ¤j¡A ¥i°Ñ¦Ò¦p¤U¡A¤j¤p«°¥« key in«á¡A¥i¨£¤@°ï»ù®æ¡C www.wellrx.com/trogarzo/monographs ¥ýÁn©ú¡Atrogarzo·íµM¤£¬O´¶®³¯k¡A¦UÃħ½ªºtrogarzo¸ê®ÆÀ³¸Ó¬OFDA³W©w¦Ó´£¨Ñ¡F ·íµM²{¬Ò¬q¡A§Ú²q·Q¥i¯à¬O¯f±w¦³ª¾ªºÅv¤O¡A¬O§_¥Ø«e¥u¦³Âå¥Í¤j¤H¯à¤U³æ¡H¡H¡H ¦ý¤w¦b¦Upharmacy¤W¬[À³¿ù¤£¤F¡I |
|
|
·|û¡G¦µ¶©°^10147391 µoªí®É¶¡:2018/10/4 ¤U¤È 12:56:41²Ä 3959 ½g¦^À³
|
Jeff, ¥Îµü¤ñ¸ûª½¡A½Ð¨£½Ì¡C ¤£¹L¡A¨º¨Ç¯uªº¬O²æÂ÷¨Æ¹ê«Ü»·¡C Áٳ·ЩâªÅÄÀºÃ¡C Ä~Äò¦³@¤ßªººCºC¬Ý¤U¥h¡C |
|
|
·|û¡GJeff10147295 µoªí®É¶¡:2018/10/4 ¤U¤È 12:42:11²Ä 3958 ½g¦^À³
|
¦µ¤j¡A Sorry! ±zªººÃ°Ý¡A±ßÂI¦^ÂСI |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/4 ¤U¤È 12:36:20²Ä 3957 ½g¦^À³
|
¶i¤@Ó¤ë¨Ó©Ò¶i¨ÓªºÉ¨÷¡A³£¬O¼È®É½ß¿ú©~¦h °£«D·í®É8¤ë¤¤¤§«eªºÉ¨÷¡A¤~¬OĹ®a ¯uªº½Ö·|Ĺ¡A«ÜÃø»¡¡A¤@¤Á³£ÁÙ¬O¬Ýº¯³z²v |
|
|
·|û¡GJeff10147295 µoªí®É¶¡:2018/10/4 ¤U¤È 12:32:57²Ä 3956 ½g¦^À³
|
¥ÍÂA¤j¡A °J¤ßªº·P®¦, ±©¨ä¦p¦¹¡A¸û½Ñ¾Fªñª©(¤º¦Kª©°£¥~¡A¤]¦³¨Ç¿þ¨¥¥Üĵ®Æ)¡A¥»ª©¤~§ó¦³¬ÝÀY¡A§l¦¬»áÂסA¦A¦¸·PÁ±z¡I |
|
|
·|û¡Gmengs10146592 µoªí®É¶¡:2018/10/4 ¤U¤È 12:29:11²Ä 3955 ½g¦^À³
|
§Ú¤]±µ¨ì¹q¸Ü¡Aɧa ¤Ï¥¿¬O¹Ç¤£¨ì³o¨Ç¤Hªº¡A¤£n·Q¤Ó¦h.. |
|
|
·|û¡Ghcs31810146781 µoªí®É¶¡:2018/10/4 ¤U¤È 12:28:23²Ä 3954 ½g¦^À³
|
·PÁ¥ͧޤjªº¤À¨É |
|
|
·|û¡G¥¤ZXYZ10147316 µoªí®É¶¡:2018/10/4 ¤U¤È 12:18:16²Ä 3953 ½g¦^À³
|
±q±b±-4xx¸U¨ì-2xx¸U ¥u¯àÀqÀq©Ó¨ü 7¤ëªì¶i³õ¡AY¯à¦A±qÀY¨Ó¤@¦¸¡A§ÚÁÙ¬O¤£½T©w¸Ó©w«ç¼Ëªº¾Þ§@µ¦²¤ ·Pı¥~¸ê¾Þ§@«Ü«O¦u¡A¤£¨£±o¯àÁȳ̤j ´²¤á«Ü³g¤ß¡A·QÁȳ̤j¡A«o®e©öÅܦ¨½ß³Ì¤j ¥t¥~Àç·~û¥´¹q¸Ü¨Ó°Ý§Ú¦Ñ±C¡An¤£n´£¨Ñɨ÷ ©Ò¥H 1. ªÅ¤è¨S¨÷¥iɤF¡H§Ú¦Ñ±C¤~21±i 2. ɨ÷½æ¥XÁÙ¨S§¹¶Ü¡H |
|
|
·|û¡GI.G.A10141282 µoªí®É¶¡:2018/10/4 ¤W¤È 11:28:31²Ä 3952 ½g¦^À³
|
¥Í§Þ¤jªÖ©w¬O¦ìÅé¶K¥Î¤ßªº¤H ÁÂÁ±z¦p¦¹¶O¤ß·j´M¡B¾ã²z¸ê®Æ»P¤À¨É¡AªÖ©wªá¤F«D±`«D±`¦hªº®É¶¡¡A¨¯W¤F :) |
|
|
·|û¡GNick10147288 µoªí®É¶¡:2018/10/4 ¤W¤È 11:16:58²Ä 3951 ½g¦^À³
|
¤p§Ì®w¦s10±i ±q¤@¸ô¶^ ¶^¨ì±b±-100¦h¸U¸}³Â¨«¤£°Ê¨ì²{¦b ¤@°_¥[ªo§a ¥t¥~«D±`·PÁ¥ͧ޷sÂA¤Hªº¤À¨É ^_^ |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/4 ¤W¤È 11:15:02²Ä 3950 ½g¦^À³
|
§ÚÓ¤H¯u¤ßı±o¥Í§Þ±±½LªÌ¡A¯uªº¬Û·íµR§Q §Q¥Î<<Âi±¤W>>¬Ý±o¨ìªº¸ê°T¡A§e²{¥X¦hªÅ¼Ë»ª ªÑ¥«¯uªº¬O¤£Åwªï¥u·|´ê¼ö¾xªº¤H¡A¤]´N¬O¤@¸ô¬Ý¦h¡A¤@¸ô¬ÝªÅ¡A³£¬O¦³·å²«ªº ÁÙ¬O¥²¶·ÀR¤ß§PÂ_¤ÀªR¡A4147 ªº½T¦³¤£¤Ö¦nªº§ë¸êªÌÄ@·N¤À¨É¸ê°T¡A¦ý»¡¦Ñ¹ê¸Ü¡AªÑ»ùÅܤƬ۷í¼@¯P¡A¯uªº¬On@±o¦í¾_Àú¡I ¦@«j¤§ |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2018/10/4 ¤W¤È 11:13:13²Ä 3949 ½g¦^À³
|
¨Ó¦ÛÁÞÅ駡¬Û¤Æªº«Â¤O ? |
|
|
·|û¡Gvito10147056 µoªí®É¶¡:2018/10/4 ¤W¤È 11:09:54²Ä 3948 ½g¦^À³
|
¤]¤Ó±j¤F, ·Qú ÁÙ¦³70¦h¸Ñ®M |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/4 ¤W¤È 10:59:26²Ä 3947 ½g¦^À³
|
¤§«e³Q¯u°²¬n¸ê¡A¹L«×¬ÝªÅ ɨ÷¤@¸ôÃk¤É ¦pÂy¤j©Ò»¡ ¯uªº½Ö¦V¤ÑÉÁx°Ú¡H XD |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/4 ¤W¤È 10:35:13²Ä 3946 ½g¦^À³
|
µ²ªGµu¼È®É¶¡¤j´T»â¥ý³Q°Ê2492 ³oªÑ¥«ªº¤H©Ê¤Ï¬M¯uÅå¤H°Ú¡A«¢ |
|
|
·|û¡GÀH½t¦Û¦b10147011 µoªí®É¶¡:2018/10/4 ¤W¤È 10:29:14²Ä 3945 ½g¦^À³
|
³B¤èÅÒ¥ÎÃĬyµ{¡G ¯f¤H¡ÐÂå¥Í¡Ð½T¶E¡Ð¶}¥ß³B¤èÃĪ«¡Ð¯f¤H¦V«OÀI¤½¥q¥Ó½Ð²z½ß¡Ð®Ö·Çµ¹¥I¡Ð¦^Âå°|±µ¨üª`®g¡C ¤£±o©óÃħ½³c°â¡A ¥¼¨ÓIM push ¦P¼Ë»ÝnÂå¥Í¶}¥ß³B¤èÅÒ«á¤~¯à¦bÂå°|§¹¦¨ªvÀø(ªÑªF·|±i¸³¡ACFO»¡ªk)¡I |
|
|
·|û¡G¦µ¶©°^10147391 µoªí®É¶¡:2018/10/4 ¤W¤È 10:13:32²Ä 3944 ½g¦^À³
|
============= ¦]¬Q±ßª¦¤å¡A¦bÂåÀøÃþºô¶¤W·j´MTrogarzo¬O§_¬ü°ê¨ì³B¾Q³f§¹¦¨¡H ªº½T¡I¤jµó¤p«ÑÃÄ©±³£¦³Trogarzo ¡A°â»ùUS$1,125~1,275/ml (©Î³\2000+800+800¤@set ¤§»ù¡Acoupon´£¨Ñ¡^ ¬Ý¨Ó¡B¥u¤í24¶g·sdataµ|ªAdoctor ªF·¡A´NÀ³¸Ó¦^´¦|¯}®ö§a¡I ============= ¡uÂåÀøÃþºô¶¤W·j´MTrogarzo¬O§_¬ü°ê¨ì³B¾Q³f§¹¦¨¡v¡A³o¬O¤°»ò¡H ¡u¤jµó¤p«ÑÃÄ©±³£¦³Trogarzo¡vþÃä¬Ý¨Óªº¡H ¡u¤í24¶g·sdata¡v¡A³o¤S¬OþÃä¬Ý¨Óªº¡H ¤S§âTrogarzo·í§@´¶®³¯k¡C ¤£¦n·N«ä¡A®¤§Úª½¨¥¡F³oÅ¥°_¨Ó´N¬O¶Ã¤C¤KÁV²ö¦W¨ä§®¡C °]°Èªø¡]§Æ±æ¨S°O¿ù¤H¡^¬YÓªk»¡¤¤´£¨ìªº§a¡A³£¬O¶°¤¤«OºÞ¡AµM«á¥ÎÃÄ«e¤@¡B¤G¤Ñ¤~ªÅ¹B¨ì¶E©Ò©Î¬OÂå°|¡C |
|
|
·|û¡GG94010145720 µoªí®É¶¡:2018/10/4 ¤W¤È 10:11:51²Ä 3943 ½g¦^À³
|
·PÁ¦U¦ì´£¨ÑÄ_¶Q¸ê°T ¥t¥~ªñ´Á ¬ü¤¸±j¡A¥x¹ô®z¡A¬Y¤è±¨Ó»¡¹ï¦¬<<¯Â¬üª÷>>ªº¤½¥q¡A¤]¬O¦³§Q°Õ XD Ä~ÄòÀR¤ßÆ[¹î |
|
|
|